A
American Board of Medical Specialties (ABMS): an organization that certifies physicians as specialists. This group comprises 24 member boards, including the American Board of Plastic Surgery. Rigorous membership standards include educational requirements, professional peer evaluation and exams.
American Board of Plastic Surgery (ABPS): the medical specialty board that certifies plastic surgeons.
analgesic: a pain reliever.
anatomical implant: a contoured or teardrop-shaped implant.
anesthesia: a numbing agent.
areola: the disc of pigmented skin around the nipple; plural: areolae or areolas.
arnica montana: an herb used to treat swelling and bruising.
American Society of Plastic Surgeons (ASPS): the professional organization of board-certified plastic surgeons.
American Society for Aesthetic Plastic Surgery (ASAPS): the sister organization of the ASPS. All board-certified plastic surgeons are members of ASPS, but ASAPS members specialize in cosmetic surgery.
asymmetrical: unequal, unmatching.
axilla: the armpit or underarm area; plural: axillae.
axillary: related to the armpit or underarm region.
B
band size: measurement of the rib cage denoted in bra sizes. It is measured in inches.
Benelli mastopexy: a type of breast lift performed by removing a circle of skin around the areolae complex and pulling in the breast tissue. Also known as a concentric, periareolar, or donut mastopexy.
bilateral: both the right and left sides. For example, a bilateral mastectomy is the surgical removal of both breasts.
board certified: an important term regarding the credentials of a physician or surgeon.
bottoming out: a condition which occurs when the lower poles (halves) of the breast slide under the inframammary crease.
breast envelope: the skin and subcutaneous tissue that covers the breast and helps give it shape.
breast lift: also called mastopexy or mastoplexy, the surgical procedure used to raise and firm sagging breasts.
bromelain: a homeopathic remedy derived from the pineapple stem which may reduce swelling and bruising.
C
capsular contracture: a complication that occurs when scar tissue forms around the implant, resulting in painful breast stiffness and possible leakage of the fluid inside the implant.
capsule: the fibrous tissue around the breast implant.
cleavage: the area between the breasts.
cohesive: marked by a tendency to stick together.
Cooper’s Ligament: the connective tissue that attaches the breast gland to the overlying skin.
cutaneous: relating to or affecting the skin.
D
dissect: to separate tissue in surgery; to place an implant, your surgeon must first create or dissect a pocket within your breast.
E
endoscopic surgery: surgery performed using an endoscope (a small camera) and special surgical tools. Endoscopic surgery usually involves one or more small incisions and a shorter recovery time than traditional open surgery.
epinephrine: a hormone secreted by the adrenal glands during conditions of stress. It raises the blood pressure and breathing rate, and constricts blood vessels.
expander implant: a temporary breast implant that is slowly inflated with saline to stretch the tissue in preparation for a permanent breast implant.
F
fascia: a sheet of connective tissue that covers or binds muscles or organs.
fibrous tissue: tissue containing tightly woven strands of collagen protein.
fluffing: a condition that occurs when the breast implants drop into a slightly lower, more natural position, after the skin and muscle have completely relaxed during healing. Also called dropping.
form stable: Another name for highly cohesive or gummy bear breast implants. Form stable breast implants are filled with viscous gel that won’t migrate in the event of a rupture.
G
general anesthesia: a type of anesthesia often used for breast augmentation. Under general anesthesia, you are fully asleep.
glandular: relating to or involving glands, gland cells, or their products.
gummy bear implants: nickname for a type of breast implants filled with highly cohesive silicone gel. This viscous filler has the consistency of a gummy bear, so if the implant ruptures, the gel won’t migrate.
H
hematoma: a break in a blood vessel, causing a blood clot or localized, blood-filled area.
hemorrhage: an abnormal flow of blood from an incision or wound.
hypoxia: lack of oxygen to the body.
I
inferior: lower or closer to the feet.
inframammary crease: the crease below the breasts where the breast envelope meets the skin over the rib cage.
inframammary incision: an incision in the inframammary crease used to place breast implants. Also called the “crease” or “fold” incision.
intercostal arteries: the arteries responsible for the blood supply to the breast.
intracapsular rupture: type of implant rupture in which a silicone-filled breast implant breaks, but the silicone is contained within the capsule.
intravenous sedation: sedation or anesthesia delivered through an intravenous (IV) line.
L
lactation: producing milk from the breasts.
latissimus dorsi flap reconstruction procedure: a reconstructive procedure that uses the latissimus dorsi (a back muscle) to form a breast mound.
lobules: the part of the breast where milk is produced. The lobules are gathered into lobes. There may be as many as 20 lobes per breast.
local anesthesia: anesthesia that numbs a small part of the body.
lidocaine: a local anesthetic, also called Xylocaine.
lumpectomy: surgical removal of breast tumor tissue.
lymph node: any of the small glands that make up the lymphatic system, which carries lymph fluid, nutrients and waste material between the body tissues and the bloodstream. The lymphatic system is a major component of the body’s immune system.
lymphadenopathy: abnormal enlargement of the lymph nodes.
lymphedema: swelling, generally in the arms or legs, that occurs when there is a blockage in the lymphatic system that is preventing lymph fluid from draining well. This tends to occur after certain types of breast cancer surgery.
M
malposition: incorrect or abnormal position.
mamma: breast, organ of lactation; plural: mammae.
mammogram: a breast X-ray.
mammography: the use of X-rays to form a diagnostic picture of the breast.
mastectomy: surgical removal of the breast or breasts and associated tissue.
mastopexy: breast lift.
micromastia: abnormal smallness of the breasts.
myectomy: excision of muscle.
N
nipple: the bulge of pigmented, erectile tissue in the center of the surface of the breast from which milk can flow.
O
P
pectoralis major: either of two large, fan-shaped chest muscles. These are the muscles that a breast implant is placed beneath in submuscular or subpectoral placement.
pectoralis minor: the small chest muscles. These muscles are targeted with a Botox breast lift.
periareolar: surrounding the areolae complex of the nipple.
pocket: a cavity made in the body by dissection. In breast augmentation, the pocket is the space created for the implant.
pole: the upper or lower half of the breast or breast implant.
ptosis: sagging.
R
regional anesthesia: anesthesia that numbs a region of the body. This type of anesthesia is not routinely used for breast augmentation.
rectus abdominus fascia: the fascia covering the rectus abdominus muscle of the abdomen. It is used to help cover the breast implant in full submuscular implant coverage.
rippling: the appearance of ridges or wrinkles in a breast implant.
S
saline: salt water.
saline-filled implants: a type of breast implant that is filled with sterile saline.
sedation: a state of calm or sleep.
seroma: a collection of fluid under the skin.
serratus muscle: a muscle on either side of the chest that is connected to, and covers, the ribs. It is used in conjunction with the pectoralis major muscle and rectus abdominus fascia in full submuscular breast implant placement.
silicone: the second most abundant element on Earth and a staple ingredient in commercial products, from pacifiers and breast implants to non-stick bakeware and adhesives.
silicone-filled implants: breast implants filled with silicone gel.
sternum: the breast bone between the two breasts.
submuscular, full submuscular: implant placement patterns. Full submuscular placement involves placing the implant entirely under the muscle.
supine: face up.
symmastia: condition characterized by touching, in the center of the chest, of the two breast implants; also called kissing implants and “uniboob.”
symmetrical: similar in size and shape.
T
tachycardia: a rapid heart rate.
thoracic: relating to or located within the thorax or chest.
thromboembolus: obstruction of a blood vessel by a blood clot; plural, thromboemboli.
thrombosis: localized coagulation of blood.
transaxillary: though the axilla (armpit).
transverse: lying or going across at an angle.
transumbilical breast augmentation (TUBA): a procedure in which breast implants are inserted via the belly button.
tubular (or tuberous) breasts: a breast shape caused by a small breast base and/or herniated areolae.
twilight sedation: a light form of sedation anesthesia that provides full sedation, but you can be roused.
U
umbilical: relating to the navel or belly button.
V
vasoconstrictor: a drug that constricts the blood vessels.
G
C H A P T E R 54
The dual plane approach to
breast augmentation
Steven Teitelbaum
History
The breast implant pocket choice has a profound effect on
the appearance of the augmented breast. Along with the selection
of the device itself, it is the most important preoperative
decision. Critical manifestations of this choice may not be
apparent for many years, as some effects of the implant on
the soft tissue occur gradually yet inexorably.
The most commonly described pocket locations are: (1)
total submuscular (subserratus and subpectoral); (2) partial
retropectoral (behind the pectoralis with its origins from the
ribs left intact); (3) subfascial (between the pectoralis muscle
fascia and the pectoralis muscle); (4) submammary or subglandular
(between the breast and the pectoralis fascia).
Total submuscular is more frequently a reconstructive technique,
less commonly done for augmentation owing to a
more painful and bloody dissection, a tendency for the device
to rise superiorly, and diffi culty in predictably creating a deep
and well-formed inframammary fold. Subfascial has not been
widely adopted due to an absence of satisfactorily controlled
or long-term data. With scarcely 0.5 – 1 mm more coverage
than a classic submammary dissection, this procedure is only
a minor variation of the submammary pocket and does not
qualify as a distinct pocket type.
Partial retropectoral and submammary are the most
popular methods. Proponents of each are quick to point
out the distinct advantages of their technique and the disadvantages
of the other. These comments are frequently
appropriate.
But these comments are not equally applicable to all situations.
There are indeed breast types for which the benefi ts
and drawbacks of one pocket makes it the better choice. Even
so, some shortcomings of that preferred pocket frequently
remain at issue.
The dual plane as fi rst published by John Tebbetts in 2001
is the ideal compromise, in that it allows the implant to be
simultaneously retropectoral where the device most needs
coverage, and retromammary where it most needs to be in
direct apposition to the breast. This allows near-total achievement
of the purported benefi ts of both at the same time,
while minimizing the trade-offs associated with selecting just
one of the two pockets. It is therefore less of a compromise
per se, than a way of “ having your cake and eating it, too ” ,
essentially doing both pockets at once, using each pocket
where it exacts its greatest benefi t.
While submammary and partial retropectoral are “ pure ”
extremes, the dual plane is a continuous spectrum of options,
occupying the “ gray-zone ” in between. The operation starts
with the creation of a partial retropectoral pocket. The origins
are carefully divided along the inframammary fold, which
allows the cut edge of the muscle to glide a bit superiorly, so
that there is both a small submammary and a large subpectoral
area of the pocket, and hence the term dual plane. By
disrupting attachments of the muscle to the overlying gland,
the muscle can be gradually and incrementally raised, thereby
reducing the proportion of subpectoral pocket and increasing
the proportion of submammary pocket. The purported advantages
of the partial retropectoral pocket are predominantly
coverage along the sternum and over the superior border of
the implant; the dual plane preserves these. The purported
advantages of the submammary pocket are to direct implant
pressure upon the lower pole; the dual plane preserves these
as well ( Fig. 54.1 ).
Criteria for the ideal pocket
Our ability to determine the ideal pocket for a given situation
rests upon the criteria that we choose to use to make that determination.
Rather than vague, subjective decisions that allow
certain issues to be overemphasized and others neglected, it is
important to attempt to quantify all of the pertinent issues and
measure each of the methods against them.
Over the last several decades, published reoperation rates
in PMA studies have not changed despite the use of different
implants, remaining consistently at about 20% at three years.
In a study of one device, a single surgeon achieved a 0%
675
Section 11: The breast
Go to www.expertconsult.com
to see updates to this chapter
0060_ch54_9780702031687.indd 675 4/8/2009 3:33:26 PM
G
Section 11: The breast
Aesthetic Plastic Surgery
676
deforming and even uncorrectable. It is therefore not enough
just to tally complications, but also to consider their
severity.
Dual plane data objectively show that this procedure succeeds
in maintaining the advantages of both pockets while
mitigating the trade-offs associated with selecting a single
pocket.
Preservation of future options in the event of an unsatisfactory
outcome is important: if Plan A was still a viable option
after Plan B, but Plan B would not be after Plan A, then that
would suggest an advantage for starting with Plan B.
Finally, outcomes need to be assessed at long intervals after
surgery. Irrevocable, permanent, progressive, and at times
totally uncorrectable changes occur to a breast years after an
augmentation. Adequacy of tissue coverage needs to be judged
at the longest possible intervals, decades if possible. Such
long-term data is meager, but owing to the importance of
such lifelong changes on the breast, at this point anecdote
and extrapolation of shorter-term results should be considered
( Fig. 54.3 ; Table 54.1 ). breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai
Pain and recovery
In general, there is less pain with the submammary approach,
as the submuscular approach subjects the sensitive rib cage
to possible trauma and the overlying muscle to stretching. But
the largest data ever assembled on postoperative pain showed
that 24-hour recovery without the use of any narcotics or
pain pumps could be routinely achieved with a dual plane
approach. Bloodless surgery and avoidance of creating any rib
trauma circumvented the typical pain experienced from the
rib cage in submuscular patients. Precise, gentle elevation,
bloodless elevation of a pectoralis muscle paralyzed by the
anesthesiologist results in a minimum of trauma to the
muscle.
This author has routinely been using these techniques for
many years, and only uses ibuprofen for postoperative pain
for routine augmentation mammaplasty in all planes, including
the dual plane. Dual plane patients routinely go out to
dinner, shower, and wash and brush their own hair the night
of surgery. They describe the feeling as “ tight ” , a “ pressure ” ,
“ soreness ” , or “ like working out hard ” .
Fig. 54.1 The three types of dual plane breast augmentation. A , Dual Plane Type I. B , Dual Plane Type II. C Dual Plane type III.
A B Complete division along IMF C
No division
No division
No divisionbreast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubaiFig. 54.2 Retromuscular pockets are often criticized for causing high-riding
implants. In this case, the dissection was a blunt/blind transaxillary
augmentation. The muscle was divided along the IMF on the left, but not the
right. This is not a shortcoming of the procedure itself, but from its execution
in this particular instance.
3-year reoperation rate in contrast to an average of 13.9% for
all the doctors in the study. Taken together, these two fi ndings
demonstrate that the outcome in breast augmentation is
determined far less by the type of the device than by other
factors ( Fig. 54.2 ).
In the absence of data, surgeons must turn to the anecdotal.
But when data is available, it trumps anecdote. Of all
endpoints, the most decisive measurement of outcome is the
reoperation rate, as it is an incontrovertible endpoint. “ Satisfi
ed ” or “ happy ” patients are imprecise and unquantifi able
endpoints, and since we have all seen unhappy patients with
beautiful results and thrilled patients despite notable problems,
they do not qualify as adequate endpoints with which
to entirely judge the quality of an operation.
The absolute incidence of reoperation tells only part of the
story: the severity of a problem must also be considered.
Some may be minor or annoying, while others may be
0060_ch54_9780702031687.indd 676 4/8/2009 3:33:26 PM
G
Chapter 54 The dual plane approach to breast augmentation
677
Fig. 54.3 A & C , Preoperative. B & D , Postoperative. Anecdotes are anecdotal, but sometimes that is the best that we have. If anyone doubts the importance of
muscle coverage, they should be shown a series of patients with tissue so thin, with a saline implant looking like this, 11 years after surgery, free from capsular
contracture, visible edges or rippling. Cases like this abound, but there are few examples of submammary or subfascial patients at this interval that look this
good.
A B
C D
When these same techniques are applied to the submammary
approach, patients typically feel slightly less stiff and
sore than do dual plane patients, but both groups still consistently
achieve a “ 24-hour ” recovery. Any difference is
subtle, noted only for a day or two, and is of no real consequence,
particularly relative to advantages of achieving more
muscle coverage.
Coverage and stretch
Soft tissue coverage is the single-most important issue affecting
the short and long-term result after a breast augmentation.
With adequate coverage, the implant edges are less
visible, and the breast looks more natural and less augmented.
Any folds or irregularities with the implant shell are more
concealed. With more tissue over it, the device is less palpable.
With less tissue coverage, the edges of the implant are
more visible, the breast looks more augmented, and it is
easier to feel the implant ( Fig. 54.4 ).
Over the long term, these changes become more profound.
Implants put pressure on the breast, and the parenchyma
gradually compresses and atrophies. The presence of the
implant stretches and thins skin. This occurs with implants
in all positions. No study will ever randomize patients of
similar tissue types and implant sizes and follow them over
enough time for a scientifi c conclusion to be made. But a large
amount of clinical observation and logic (see Fig. 54.3 and
Fig. 54.5 ) offers us guidance.
Examples of submammary patients with severe parenchymal
atrophy abound, while retropectoral patients with similar
characteristics are rarely seen. And when they are, though the
implants may have ostensibly been placed “ behind the
muscle ” , secondary surgery frequently reveals that the muscle
has been avulsed off both the inframammary fold and
sternum, thereby sacrifi cing the critical coverage of which we
are speaking ( Fig. 54.6 ).
These problems are sometimes noticeable within a year or
two, but can often take years more to develop. We must be
0060_ch54_9780702031687.indd 677 4/8/2009 3:33:28 PM
G
Section 11: The breast
Aesthetic Plastic Surgery
678
Table 54.1 Pocket comparisons
Issue Advantage
PRP
Advantage
subglandular
Dual plane remedies
Less pain X Best data to date
Better coverage X Large advantage vs. SM; difference relative to PRP
dependent upon release and up to determination of
surgeon
Access to lower pole parenchyma X Yes
Expands constricted breasts X Yes
Fills ptotic breasts X Yes
Avoids muscle animation X Rarely clinically signifi cant
Reduces tendency to “ ride high ” X Yes
Reduces tendency to “ lateralize ” X Yes
Faster recovery X Best data to date
Less capsular contracture X Best data to date
Better for mammograms X Appears to be
Reduce parenchymal atrophy X Best data to date
Reduces stretch deformities Best data to date
Narrower cleavage X No – but subglandular can only do so at the expense of
coverage
Fig. 54.4 Tissue coverage is always a priority, particularly superiorly and
medially. The implant she holds in her hand mimics what is occurring within
her breast. With muscle coverage in the upper pole, such a deformity will
rarely if ever occur.
Fig. 54.5 This is not a capsular contracture. This is a submammary implant.
The breast is soft. The patient chose this at the surgeon ’ s behest in order to
avoid animation deformity. But even in repose, the signifi cant deformity is
present; there is no substitute for soft tissue coverage.
aware of these problems and remind ourselves that we need
to create a result that will look good not just for years, but
for decades. As someone who sees many secondary problems,
I can state categorically that subglandular patients present
more frequently, with more severe problems, and with more
unsolvable problems than do subpectoral or dual plane
patients.
Such tissue thinning with submammary patients also is a
set up for a problem which is diffi cult to correct, as to do so
often requires a switch to the partial retropectoral or dual
plane position. But once there is a subglandular pocket, the
coverage in the retropectoral pocket is forever impaired.
Though one can use sutures to tack the muscle back up to the
gland, its caudal cut edge can never be retained as caudally
as it might have been were this not to have happened, thereby
forever impairing inferior coverage. Marionette pullout
sutures have been described to hold down the muscle in this
situation, but this also cannot achieve the same degree of
0060_ch54_9780702031687.indd 678 4/8/2009 3:33:31 PM
G
Chapter 54 The dual plane approach to breast augmentation
679
Fig. 54.6 This patient just had removal of subpectoral implants. The
dotted line indicates the caudal border of the pectoralis. Though she had
“ retromuscular ” pockets, the implant itself had negligible if any coverage as
the muscle was so high it could cover only a bit of the implant, and the
pressure of it probably pushed the implant away. Though her muscle was still
attached to the sternum, the muscle had been inadvertently detached from
the overlying parenchyma, thereby allowing it to window shade up far higher
than would be ideal even for a DP III.
Fig. 54.7 This patient had a submammary capsulectomy and then had a
submuscular pocket dissected. It illustrates the basic principle of the DP
approach. With no attachment of the muscle to the overlying parenchyma,
this muscle window shades strongly superiorly. The DP approach recognizes
the importance of maintaining those attachments when it is important to
keep the muscle inferiorly to maintain coverage, and emphasizes the
importance of a gradual and incremental release of them to allow controlled
vertical elevation of the muscle and exposure of the parenchyma in the lower
breast when the situation demands.
Fig. 54.8 The most common argument for submammary placement is to deal with the postpartum involution and ptosis patient who does not want
mastopexy scars. But this group has the thinnest tissue and is the most prone to stretch and thinning. A , A patient merely two years following such a
procedure; note the extreme parenchymal atrophy and skin thinning. B , Note the improvement still noted two years after conversion to a dual plane.
A B
coverage as if the attachments between the muscle and the
overlying gland were never disrupted ( Fig. 54.7 ).
In conjunction with the thinning, there is often progressive
stretch of the skin envelope, sometimes necessitating mastopexy.
Even if this mastopexy would have been inevitable in
the future with a partial retropectoral or dual plane pocket,
such patients frequently have soft tissue thinning or capsular
contractures in addition to the stretched skin. This necessitates
a pocket change and possible capsulectomy in addition
to the mastopexy, which can be a riskier procedure than if the
implant had started out dual plane or partial retropectoral.
This combination of secondary revision occurs so frequently
that efforts must be made at the time of the original surgery
so that this doesn ’ t happen ( Fig. 54.8 ; also see Fig. 54.5 ).
If tissue coverage is adequate, it almost doesn ’ t matter what
is going on with the implant; a capsular contracture may be
less noticeable; suboptimal implant shape may be less problematic;
implant folds might be harder to discern. These are
powerful reasons to select the partial retropectoral pocket
over the submammary pocket.
But what should one do if there is glandular ptosis or a
constricted lower pole and the tissue is thin? Partial retropectoral
is preferred for the tissue coverage issue, but submammary
may be necessary to allow better expansion of the lower
pole. The dual plane solves this dilemma by allowing the
upper and inner portion of the implant to be covered by
muscle, while the inferior portion, the part that needs to push
directly on the gland to expand and fi ll it, can be allowed to
be in direct apposition.
Achieving “ adequate ” coverage is an insuffi cient goal.
“ Maximum ” coverage must be the goal. There is almost no
long-term problem that is not solvable when substantial soft
tissue is available, and there are few problems completely
correctable when soft tissue is not available.
There is some sacrifi ce in coverage with the dual
plane relative to partial retropectoral, and if tissue coverage
in the lower pole is such that the benefi ts of changing to the
dual plane do not outweigh its advantages, then it is suggested
to patients to have a partial retropectoral pocket.
In any case, the reduction in coverage with the dual
0060_ch54_9780702031687.indd 679 4/8/2009 3:33:33 PM
G
Section 11: The breast
Aesthetic Plastic Surgery
680
plane relative to partial retropectoral is reasoned and
controlled.
Access to parenchyma
The most profound advantage of submammary over partial
retropectoral is attributable to the direct pressure the implant
can make against the gland. This can make it look less empty,
and the pressure can better expand a tight lower pole. If
behind the muscle, the muscle essentially protects the preexisting
confi guration of the lower pole, inhibiting the
implant ’ s ability to push it and fi ll it out. And if weak fi brous
connections between the pectoralis muscle and breast gland
allow the gland to slipe relative to the muscle, placing the
implant against the breast tissue can help reduce the extent
of inferior tissue migration. Otherwise, the subpectoral placement
still allows the gland to slide inferiorly relative to the
muscle ( Figs 54.9 and 54.10 ).
Depending upon the degree of release with the dual plane,
these advantages of the submammary approach can be almost
completely if not completely realized with the dual plane
approach. The coverage that is preserved superiorly and medially
typically allows for muscle coverage where it is most
needed: superiorly and along the medial sternal border.
Capsular contracture
Capsular contracture still remains the leading cause of reoperation
in PMA studies, yet publications using antibiotic irrigation
and the dual plane pocket have resulted in some of
the lowest reported capsular contracture rates to date. Whether
it is specifi cally due to the dual plane per se or other factors,
such as the irrigation, is not entirely clear. But it is suffi cient
to say that the lowest reported capsular contracture rates are
with the dual plane position, and no paper suggests an advantage
to partial retropectoral over dual plane. Dual plane is the
ideal choice.
Mammography
Given the cancer prone nature of the breast, optimizing the
ability to detect cancer early must remain a priority. Numer-
Fig. 54.9 The long term stability of the outcome in this post partum atrophy/ptosis patient with implants in the dual plane position demonstrates the value of
proper implant sizing and tissue coverage.
pre 5 months 1 yr
2 yrs 3 yrs 5 yrs
0060_ch54_9780702031687.indd 680 4/8/2009 3:33:37 PM
G
Chapter 54 The dual plane approach to breast augmentation
681
ous authors have suggested an advantage to retropectoral over
submammary placement for this regard, but it is unclear
whether the advantage is directly due to the anatomic location
relative the muscle itself, or due to a lower capsular
contracture rate below the muscle. Suffi ce to say, mammogram
is impaired when the breast tissue cannot be pulled out
and away from the implant and placed between the mammogram
plates, such as when the implant is hard, there is a
large implant relative to the breast tissue, or any other reason
that restricts the pull of the tissue forward. While no studies
have specifi cally compared sensitivity of mammogram
between these pockets over a long period of time, the low
incidence of capsular contractures and the extensive muscular
coverage over a dual plane implant suggests that this would
not be a problem. In any case, the role of MRI in screening
for breast cancer is increasing, even for women without breast
implants. And since implants do not affect its sensitivity, this
entire issue may soon be moot.
Muscle animation breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai
The lack of signifi cant implant motion or distortion with
contraction of the pectoralis is a signifi cant advantage of the
submammary position relative to the partial retropectoral
pocket. But it is not enough to look at the problematic subpectoral
patients with animation problems: one must also
be aware of the submammary patients with signifi cant
implant visibility even in repose. The deformity of a thin
patient with subglandular implants at rest is typically more
profound than a partial retropectoral patient during maximal
contracture.
With the dual plane approach, the release of the pectoralis
along the inframammary fold (IMF) reduces if not totally
eliminates the forces that might distract the implant superiorly.
While the medial origins along the sternum may compress
and slightly lateralize the implant on strong contraction,
they rarely cause a signifi cant deformity ( Fig. 54.11 ).
Fig. 54.10 The constricted lower pole breast is frequently touted as being a reason for submammary, as it allows scoring of the lower pole. In this case, shown
here at 5 years post-surgery, a DP II was done, allowing the muscle to rise to the lower border of the areola. This exposed parenchyma for the entire lower pole
of the breast, allowing it to be shaped just as much as it would have been were this to have been a submammary placement, but with maintenance of muscle
coverage superiorly and medially, which helps to obscure the borders of the implant.
0060_ch54_9780702031687.indd 681 4/8/2009 3:33:39 PM
G
Section 11: The breast
Aesthetic Plastic Surgery
682
Certainly, there is some motion, but in the Tebbetts series,
there was no revision requested for this reason. In my experience,
there has been occasional complaint and discussion of
revision, but I have not switched my own patient to a submammary
pocket for this reason ( Fig. 54.12 ).
Usually, the patients with any such problems are very
thin, and were therefore the least well suited for a submammary
pocket. The key in minimizing animation with the dual
plane pocket is to uniformly and accurately take the muscle
down along the inframammary fold, stopping evenly on both
sides at the point at which the IMF meets the sternum, and
never releasing along the sternum. It appears that when the
IMF is horizontal and meets the sternum at a discrete point,
these issues are less problematic than when the IMF curves
sharply superiorly as it moves towards the sternum, oftentimes
not actually meeting the sternum until being at or even
above the level of the nipple. These patients are also often
thin, and they represent a particular challenge, in that there
in fact may be no way to avoid some deformity with either
approach.
Fig. 54.11 A critical step of all dual planes – I, II, and III – is to completely
divide the pectoralis major along the inframmary fold, stopping at the
sternum, without division along the sternum. Failure to divide the origins
along the IMF result in either a high-riding implant, superior malposition with
animation, or a blunted IMF. However, if tissue coverage is thin ( < 5 mm), they
probably should not be divided, as maintaining coverage is the fi rst priority.
Division along the sternum can result in symmastia, excessive edge visibility
and uncorrectable deformities.
Complete division along IMF
No division
Fig. 54.12 DP and all retromuscular pockets are criticized for animation deformities. But the patient needs to be considered in repose as well. Here the same
patient on the top is seen submammary, relaxed in two different poses. Though there is no animation deformity, the implants are unattractive. In the lower left,
she is shown relaxed in the DP position, looking much prettier and more natural. In the lower right, she does demonstrate distortion with contracture, but no
doubt even if this is the maximal distortion she can manage, it is still less deformed than she looks in either of the preoperative views in repose.
0060_ch54_9780702031687.indd 682 4/8/2009 3:33:44 PM
G
Chapter 54 The dual plane approach to breast augmentation
683
No matter which pocket is selected, the patient must be
fully informed preoperatively of the trade-offs, and participate
in the pocket selection. That way, if she has an animation
deformity or implant deformity later, she can be reminded
that she preferred accepting that problem to the risks of the
other pocket. If a patient is not made aware of these choices
preoperatively, then dissatisfaction and request for revision
remain avoidable risks for revision.
Narrower cleavage
Both partial retropectoral and dual plane procedures accept
the inner border of the pectoralis major muscle as an absolute
limit to the medial placement of the implants. Once submammary,
the implant can certainly be more medial.
However, this comes at a price: the patients who most request
or “ need ” such medialization invariably have the least soft
tissue cover, and moving the implant medial to where the
internal border of the pectoralis origin on the sternum results
in risking symmastia and excessively visible implant edges. It
is foolhardy to attempt to create cleavage by excessive medial
placement of any implant, as tight skin usually pushes the
implant laterally and the thin skin results in distinctly visible
edges. So while the submammary does have the potential to
place implants more medially, this amounts to more of a
liability than an advantage.
Physical evaluation
Until experienced, most surgeons believe that an operation is
all about what happens the day of surgery. In fact, it is the decisions
that lead up to surgery that often have the most long-term
effects on a result. This is particularly true of breast augmentation,
where patient wishes, patient anatomy, and surgeon
judgment converge. This topic is more important than pocket
choice or any other issue with breast augmentation alone. The
following are the most important of these points:
Patient education
The patient must be informed about the limitations of her
tissue, so that her expectations are met. She must anticipate
all trade-offs with respect to issues such as tissue coverage,
animation, correction of ptosis, etc. When patients participate
in these choices and sign off on them, the incidence of revision
surgery is reduced and patient satisfaction increases.
Determination of ideal implant size
A patient is asked to decide whether she wants an implant
that fi ts properly within her tissue, or she wants to force a
certain size into her breasts without regard for creating an
unnatural result in the short term and causing permanent
tissue changes in the long term. Informed patients will usually
select the latter. In that case, using the base width, skin stretch,
and degree of envelope fi ll, the ideal implant size for that
patient ’ s breast is determined. Larger will have an upper convexity
and look more full, stuffed, or fake. Smaller will have
a concave upper pole and look emptier.
Determination of need for coverage and for
muscle release breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai
The dual plane preserves coverage and allowing coverage
where it is needed. These two opposing characteristics need
to be evaluated in all patients.
Coverage
It is always a goal to maintain as much coverage as possible,
sacrifi cing coverage only when there is a reason to do so. With
the exception of patient request (after being fully informed),
a dual-plane approach is suggested to all. If coverage is < 2 cm
of pinch at the upper pole, then a submammary approach
will not even be offered. If pinch < 5 mm at the IMF, serious
consideration is given to not releasing the muscle to create
the dual plane, choosing instead to use a partial retropectoral
pocket. In such situations, the long-term benefi ts of preserving
maximal coverage often outweigh animation deformities,
widening of the intermammary distance, and the predictability
and crispness of the inframammary fold position.
Muscle release
The breast is examined for lower pole constriction or glandular
ptosis that might necessitate controlled release of the
muscle from the gland. While one might decide specifi cally
preoperatively to perform a dual plane type II or type III, the
surgeon should always start by dissection a type I, and then
examine and feel the breast, releasing as much as is necessary
during the operation.
Need for mastopexy
Many patients see plastic surgeons for a breast augmentation
following lactation or weight loss. For some of these women,
mastopexy is the appropriate procedure. Not wanting scars,
some of these patients either receive an implant that fi lls, but
is larger than they wish, or an implant of the size they want
but which creates inadequate fi ll. In either case, and in particular
in the case of the larger implants, the result is aesthetically
compromised, and the already stretched skin stretches
more and deteriorates with time. I have seen many such
patients who had received submammary augmentations, and
have tried this on my own patients. If followed long enough,
the results are frequently unsatisfactory. Neither is the dual
plan an answer for these patients; if the nipple (N) is below
the fold, if N : IMF distance is > 9.5 cm on maximum stretch,
or if substantial parenchyma lays caudal to the inframammary
fold, mastopexy must be considered, and augmentation
should either not be attempted or only performed on the
patient who clearly demonstrates an understanding of the
limitations of such a procedure (see Fig. 54.8 ).
Anatomy
The pectoralis major muscle has origins along the clavicle,
sternum, and the 4th – 6th ribs along the IMF, and inserts onto
the humerus, causing fl exion and internal rotation. Studies
0060_ch54_9780702031687.indd 683 4/8/2009 3:33:48 PM
G
Section 11: The breast
Aesthetic Plastic Surgery
684
have demonstrated that the pectoralis origins along the IMF
can be released without loss of strength or coordination.
What is most relevant to the dual plane is the recognition
that the deep surface of the pectoralis glides over the chest
wall. It is anchored like a trampoline on three sides to the
humerus, clavicle, and ribs. Like a trampoline released on one
edge, the muscle will retract strongly away from the side of
the release.
The only thing that holds it in place – in distinct contrast
to its deep surface – is that its superfi cial surface is tightly
bound to the deep surface of the gland. The superfi cial surface
of the muscle gives rise to the Cooper ’ s ligaments and fi brous
tissue that ramify throughout the breast. These attachments
help hold the caudal edge of the muscle inferiorly, thereby
maintaining coverage to the lower pole of the implant.
Following careful release of the muscle along the inframammary
fold, the surgeon will observe the muscle “ window
shade ” , sliding superiorly 1 – 2 cm. However, if there was an
inadvertent dissection on the superfi cial surface of the muscle,
thereby disrupting some of the fi bers connecting the muscle
to the overlying gland, the muscle will window shade far
more, sacrifi cing what might be intended coverage of the
lower pole.
This point is most emphasized when creating a retropectoral
pocket following a submammary capsulectomy. Even if
the pectoralis origins along the IMF are left intact, the caudal
edge of the muscle window shades very high superiorly; if
those origins are released, it may move so high that it cannot
even cover the implant at all. Understanding this dynamic is
critical to the dual plane approach.
Technical steps
See Table 54.2 ; see also Fig. 54.1 .
Though a dual plane dissection can be done from all
incisions, the inframammary incision allows the greatest
degree of visualization and control of the dual plane pocket.
Most specifi cally, it allows preservation of all the attachments
between the muscle and the overlying gland, so that
if they need to be dissected, it can be done in a specifi c
and controlled manner. Dissection from the periareolar
incision down to the inframammary fold or the proposed
level of transection of the muscle invariably results in some
degree of inadvertent disconnection of the muscle from the
overlying gland, thereby resulting in unintentional superior
elevation of the muscle, creating for example a dual plane
type II or III when a type I was the goal. I frequently
perform revision surgery on patients who had periareolar
augmentation in which the operative note described the
procedure as “ partial retropectoral ” and described only division
of the muscle along the inframammary fold, yet the
caudal edge of the muscle is frequently found well above
the upper border of the areola, beyond what is even considered
a dual plane III. This may be due to a combination
of a bit of release of the muscle along the sternum, but it
seems more commonly due to a release of the attachments
of the superfi cial surface of the muscle from the gland
simply as part of the tunneling process to reach the inframammary
fold. Unless a DP II or III is a goal, a surgeon
should probably perform dual plane pocket surgery from
the inframammary incision until they have gained substantial
experience.
Many surgeons divide the muscle along the inframammary
fold and describe the procedure as “ half over – half under ” ,
or even “ partial retropectoral ” , which is exactly what is
described as a dual plane type I. Whatever the label, these
surgeons should always be cognizant that the loss of tissue
coverage from a periareolar incision is always a risk unless
extremely fastidious dissection is done.
Table 54.2 Technical steps
Description Indication Goal
Partial retropectoral Pectoralis attached to
sternum and to IMF
IMF pinch < 5 mm Maintain maximum coverage
Dual plane type I Same plus complete division
of pectoralis along IMF
All parenchyma above IMF; gland
adherent to muscle; A : IMF on
maximum stretch 4 – 6 cm
Small sacrifi ce in coverage to increase IMF
accuracy; reduce animation deformity;
allow implant to sit at bottom of pocket
Dual plane type II Same plus pectoralis released
from overlying gland and
allowed to slide to about the
lower border of the areola
Most parenchyma above IMF; looser
attachments of gland to muscle with
some sliding of gland over muscle;
stretched lower pole skin with A : IMF
under maximum stretch 5.5 – 6.5 cm
More sacrifi ce in lower pole muscle
coverage in order to reduce risk of mobile
parenchyma from sliding off of muscle,
better fi ll of loose envelope
Dual plane type III Same plus greater release of
pectoralis from gland,
allowing it to slide to about
the upper border of the
areola
Ptosis with one-third or more of
parenchyma below level of anticipated
IMF with patient standing; substantial
sliding of gland over muscle; more
stretched lower pole skin with A : IMF
under max stretch 7 – 8 cm or constricted
lower pole breasts
Most sacrifi ce in lower pole muscle
coverage to allow maximal contact of
implant against gland; allows for maximal
scoring/reshaping of gland to allow
maximal expansion
0060_ch54_9780702031687.indd 684 4/8/2009 3:33:48 PM
G
Chapter 54 The dual plane approach to breast augmentation
685
Likewise, a DP I, involving only the release of the pectoralis
along the inframammary fold, can be undertaken from
the transaxillary incision. Unlike a blunt and blind transaxillary
approach which risks uneven release of the muscle and
imprecise level of the inframammary fold, a true DP I transaxillary
should be done with a bloodless, endoscopic technique.
Creating a DPII or III, however, involves retrograde
dissection from the transaxillary incision. This remains on the
technical fringe at this time, and should be undertaken by
surgeons experienced with endoscopic transaxillary partial
retropectoral pocket creation after experience with the dual
plane for a variety of situations from the inframammary
incision.
IMF approach
See Fig. 54.13 .
The fi rst step is to determine the ideal position of the
inframammary fold. It is calculated from the nipple with the
tissue placed on maximum stretch. In general, the standard
of 7 cm for a base width of 11 cm, 8 cm for a base width of
12 cm, and 9 cm for a base width of 13 cm holds true. If the
inframammary fold is already at that height, it does not need
to be altered.
An incision is made at the proposed inframammary fold.
Dissection is carried straight down to the muscle fascia with
the electrocautery, taking care not to skive inferiorly. There is
a natural tendency of the cut edge of the tissue to pull inferiorly,
so the dissection may angle superiorly, but only for the
purpose of not undercutting the skin edge and inadvertently
lowering the fold more than intended, if at all.
The fascia is scored carefully with the cautery, so that the
muscle is visible. Place in a double-ended or army-navy
retractor with the tip pointed towards the medial border of
the areola. With no horizontal dissection yet made, there will
be little to hold the tissue up onto the blade of the retractor,
so use the ulnar fi ngers of the retractor holding hand to pull
the tissue onto the blade. Lift up towards the ceiling. Only
the pectoralis will tent up. If the muscle does not tent at this
point, it may be that the muscle is tight, or it may be that it
is not the pectoralis. To ensure that it is pectoralis, and neither
serratus, rectus, nor intercostals, touching it with the cautery
will make the pectoralis in the upper chest contract. If still
not clear, only then dissect just a couple of millimeters along
the muscle surface in a cephalad direction. These are the
important fi bers that you want to preserve in order to hold
the muscle down after you release along the inframammary
fold, so sacrifi ce no more than necessary for the anatomy to
be clear. This will allow you to see the fi bers of the muscle,
and allow some tissue to lie over the blade of the retractor,
thereby allowing the pectoralis to tent up.
Again advance the retractor blade to the edge of the muscle,
pointing the blade to the medial border of the areola, pulling
the breast tissue onto the retractor, and lifting toward the
ceiling. Because it is loose on its deep surface, the pectoralis
will tent upwards. Holding your hand down onto the
abdomen so that the cautery is horizontal, sweep gently the
taught pectoralis fi bers that appear vertical in front of you.
Use hand switching monopolar forceps, as it allows precise
control of blood vessels by squeezing, but so too can it be
held together and used as a Bovie pencil.
So long as it tents, it is pectoralis. So long as your cautery
is horizontal and parallel to the chest wall, the chest is safe.
Keep advancing the retractor forward and lifting up after every
stroke of the cautery. With each motion of the cautery and
repositioning of the retractor, the muscle will tent higher and
the plane through the muscle will become more obvious.
With this maneuver, you will very quickly get through the
muscle, and will see the subpectoral space. Free up areolar
tissue that is immediately in front of the incision, and then
turn the retractor blade medially along the inframammary
fold towards the sternum. Controlling the tension of the
retractor blade on the muscles with fi ngers on the outside of
the breast, use the cautery to take down the muscle about
1 cm above the proposed inframammary fold. This may serve
as a shelf to help support the implant; it prevents over lowering
of the fold; and it allows point coagulation of intramuscular
blood vessels. Cut through the muscle and the overlying
fascia. This should be bloodless and very easy to visualize.
In fact, this dissection is so anatomic, that you should
expect to be able to do it without needing to place a single
four by eight into the pocket. Look beyond the tissue plane
immediately in front of you, anticipating and seeing the perforators
ahead of time.
Continue all the way to the sternum, but do not proceed
up the sternum at all. If you are unclear where this point is,
mark it with an “ X ” externally on both sides preoperatively.
Continue the dissection sweeping superolaterally, and
then sweeping inferiorly. This helps to fi nd the plane between
the pectoralis major and pectoralis minor, which are more
intertwined if the dissection in that area starts inferolaterally
instead of superolaterally.
Irrigate with antibiotic solution and inspect the pocket.
Take note of the long, narrow V -shaped trough where the
muscle was released inferomedially and window shaded a
bit superiorly. Inspect where the cut edge of the pectoralis
is relative to your incision; sometimes it is just a few millimeters
beyond it, and sometimes it is already window-shaded
several centimeters. This will vary based upon how cleanly
you got through the pectoralis and how tight the given
patient ’ s connections between the pectoralis and breast tissue
are.
Place a fi nger in the incision and feel the lower border of
the muscle and lift up, taking note of the position of the
muscle through the skin as shown by the position of your
fi nger. This inspection process is not just important in order
to defi ne what you need to do for that specifi c patient, but
done repeatedly, it provides the surgeon with a valuable experience
about the dynamics of the muscle and the soft tissue.
If the intention is to do a dual plane I, by virtue of the
muscle release, the dual plane portion of the dissection is
complete. The implant can be placed and the incision
closed.
If the goal is to do a dual plane type II or type III, then
now is the time to do a release. This release is gradual and
incremental. It cannot be overstated that substantial differences
in position of the caudal edge of the pectoralis are
created by just several millimeters of dissection. Surgeons ask
0060_ch54_9780702031687.indd 685 4/8/2009 3:33:48 PM
G
Section 11: The breast
Aesthetic Plastic Surgerybreast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubaiFig. 54.13 A & B , After the retropectoral pocket is made, the pectoralis is divided 1 cm above the proposed inframammary fold. Note the use of the ulnar digits
on the retractor hand pressing the muscle under tension so that it splits as it is divided. The superior and inferior cut edges are visible. When this is divided up
to the sternum, a dual plane I will have been created, as shown in this photo. Depending upon the tension of the tissues, the muscle will window shade up a
centimeter or two; in this case the muscle is about half the width of the retractor blade above the IMF. C , To go from a dual plane I to a II or III, the fi brous
connections between muscle and the overlying parenchyma must be taken down. Just a few sideways swipes with the cautery is enough to cause signifi cant
movement of the muscle. D , After just a few swipes of the cautery freeing up some attachments of the muscle to the gland, the muscle moves cephalad. The
fresh yellow fat shows the signifi cant motion of the muscle relative to the last photo. Again, note the use of the ulnar digits against the retractor to create
tension at the muscle parenchyma border, thereby making the dissection more precise and facile. E , When converting to a DP I to a II or a III, note how the
hand and the retractor are used as a unit to create tension at the muscle/parenchyma interface. F , Here the release is being done more laterally. It can be
adjusted on each breast exactly as the conditions necessitate. G , Copious irrigations with “ Adams ” solution (50 mL Betadine, 80 mg gentamicin, 1 g Ancef in
500 mL NS) is used throughout the operation. Note the yellow fat visible just beyond retractor; cut edge of muscle is just visible. H , In this case, the muscle is
released to the lower border of the areola, which is a so-called dual plane II. When it is released to about the upper border of the areola, it is termed a DP III.
A
G H
E F
C D
B
0060_ch54_9780702031687.indd 686 4/8/2009 3:33:49 PM
G
Chapter 54 The dual plane approach to breast augmentation
687
why they can ’ t dissect between the muscle and the gland
before the muscle dissection, and the reason is that such small
amounts of dissection result in such signifi cant movement of
the muscle, that it is impossible to predict where the muscle
will end up before dissecting the pocket and releasing the
IMF.
With the curved end of a double-ended retractor placed in
the incision, abutting to the caudal edge of the muscle, but
with only breast tissue within it, use the other fi ngers in the
retractor hand to push in on the breast, so that together with
the retractor, it is putting tension between the muscle and the
overlying gland.
Visualize the fascial connections between the muscle and
gland, and use the cautery to gradually cut these, using sideways
sweeping motions. You will see the muscle quickly pull
away from the retractor and slide upwards. Once it does this
even for several millimeters, move the retractor medially and
laterally and repeat this process where you feel there is restriction
by the muscle.
Rather than repeating this motion in the same area, keep
moving around, as this will give the most control over the
fi nal position of the muscle.
While illustrations suggest dual plane type I, II, and III as
distinct entities, they are part of a continuum of options.
Their designations are designed as a guide to enable us to
think about a clinical situation and compare notes. But in any
given patient, the muscle does not necessarily end exactly at
the lower border of the areola (type II) or the upper border
of the areola (type III). Rather, the release is made to the
extent that is necessary to achieve the exposure of the implant
to the gland of the breast.
The most important point is not to overdo it. You can
always release more, but once it is released, it is diffi cult if
not impossible to pull the muscle back down. Put your fi nger
back in as you did before, and note the chance in position of
the muscle relative to before you did the release. Feel all along
its edge, and go back and release more where you feel it is
necessary.
If you feel bands within the breast that are restricting
expansion, such as with a constricted lower pole, or when the
IMF had to be lowered with a tight IMF, now would be the
time to score the lower pole, much as you might have done
with a submammary pocket.
Irrigate again with antibiotic solution, recheck for
bleeding, and place the chosen implant close per the usual
routine.
Postoperative care
With precise visualization of the pocket, no special bras or
straps are necessary to try to push the implant into a pocket.
Tape or a Steri-strip over the incision is the only dressing that
is used.
With bloodless dissection, no special bandages are necessary
to create compression, and early motion is not just
allowed, it is ordered. Patients move their arms over their
head in the recovery room in a gradual jumping jack type of
motion. They go home, take a nap, and then are instructed
to continue their exercises every hour while awake, take a
shower, and leave the house for dinner. They may drive a car
when they feel that they can safely make unrestricted movements,
which is usually in two to four days. They are encouraged
to do all normal daily activities that do not involve
particular exertion, such as opening and closing car doors,
putting on a seatbelt, lifting a baby, emptying a dishwasher,
or making dinner. They may return to the gym after three
weeks, though some surgeons allow this after two weeks.
With gentle, precise, and bloodless dissection, patients are
only given narcotics through their time in the recovery room,
and are managed over 95% of the time with ibuprofen alone
at home.
Complications
There is no complication of dual plane that has not been
well-described with either the submammary or partial retropectoral
operations. The issue with dual plane is not that
there are new complications, but that the patient and surgeon
understand its limitations. So long as these trade-offs are well
understood preoperatively, they are accepted later.
For instance, in cases of extreme mobility of the breast over
the underlying chest wall, inferior sliding of tissue may still
occur with the dual plane approach. It is my impression that
in extreme cases of laxity this may occur more with the dual
plane than the submammary approach, but this is diffi cult to
quantify because even the submammary approach does not
always totally solve the problem.
Though dual plane can reduce muscle animation relative
to partial retropectoral, it cannot eliminate it to the same
extent as the submammary pocket. Patients need to be aware
of this, and make their decision about the pocket they
prefer.
0060_ch54_9780702031687.indd 687 4/8/2009 3:33:53 PM
G
Pearls & pitfalls
Pearls
• When you have a choice in breast augmentation, always
prioritize coverage. This will make the breast more natural in
the short term and reduce the likelihood of diffi cult to
correct long-term problems.
• Point out all limitations a patient ’ s pre-existing anatomy
poses on her result preoperatively. This will help her to let
you do what you think is best for her, and will prepare her to
accept trade-offs and shortcomings in her result later.
• With the dual plane, dissect a partial retropectoral pocket
fi rst. The more directly you are able to get behind the
muscle, the less it will move superiorly after muscle division.
• Do not force yourself to choose which type of dual plane you
will do; these are not so much distinct entities as points on a
path. You should feel the breast during the dissection and
adjust the dissection accordingly.
• Demand of yourself to make a gentle and bloodless pocket
dissection so that your patients have an easy recovery.
Pitfalls
• The dual plane is not perfect, and though it maximizes most
of the advantages and minimizes most of the disadvantages
of either the submammary or partial retropectoral pockets,
neither the surgeon nor the patient should think that it is
perfect.
• It is easy to over-dissect the attachments between the
muscle and gland; avoid excessive dissection in that plane
before dividing the pectoralis along the IMF, and then only
release gradually and incrementally.
• Do not release the pectoralis ever along the sternum; it
creates deformities that are diffi cult to correct.
Summary of steps
1. Partial retropectoral: Pectoralis origins left intact along
sternum and IMF.
2. Dual plane type I: Pectoralis origins left intact along
sternum, but divided along the IMF.
3. Dual plane type II: Same plus pectoralis released from
overlying gland and allowed to slide to about the lower
border of the areola.
4. Dual plane type III: Same plus greater release of pectoralis
from gland, allowing it to slide to about the upper border
of the areola.
Further reading
Adams WP Jr . The process of breast augmentation: Four sequential
steps for optimizing outcomes for patients . Plast Reconstr Surg
2008 ; 122 ( 6 ): 1892 – 1900 .
Adams WP Jr , Rios JL , Smith SJ . Enhancing patient outcomes in
aesthetic and reconstructive breast surgery using triple
antibiotic breast irrigation: Six-year prospective clinical study .
Plast Reconstr Surg 2006 ; 118 ( 7S ): 46S – 52S .
Spear SL , Carter ME , Ganz JC . The correction of capsular
contracture by conversion to “ dual-plane ” positioning:
Technique and outcomes . Plast Reconstr Surg
2006 ; 118 ( 7S ): 103S – 113S .
Tebbetts JB , Adams WP . Five critical decisions in breast
augmentation using fi ve measurements in 5 minutes: The
high fi ve decision support process . Plast Reconstr Surg
2006 ; 118 ( 7S ): 35S – 45S .
Tebbetts JB . Achieving a zero percent reoperation rate at 3 years in
a 50-consecutive-case augmentation mammaplasty premarket
approval study . Plast Reconstr Surg 2006 ; 118 ( 6 ): 1453 – 1457 .
Teitelbaum S . The Inframammary approach to breast
augmentation . Clin Plast Surg 2009 ; 36 ( 1 ): 33 – 43
Section 11: The breast
Aesthetic Plastic Surgery
688
0060_ch54_9780702031687.indd 688 4/8/2009 3:33:53 PM
Please see inside for Indications and Important Safety Information.
ART. SCIENCE.
A collection as diverse as your patients,
Natrelle® is the #1 plastic surgery portfolio.1,2,*,†
Shaping the future
with you
*Based on surgeon survey data, December 2016 (N = 100).
†Based on US market share data through November 2016 (N = 67).
ART. SCIENCE.
Table of contents
Indications and Important Safety Information 2
Natrelle®—the most complete portfolio 8
The Natrelle INSPIRA® Collection 13
Natrelle® 410 Anatomical Gel Breast Implants 23
Natrelle® Saline-Filled Breast Implants 31
Natrelle® 133Plus Tissue Expanders 36
Natrelle® 133 Tissue Expanders 41
Natrelle® tissue expander accessories 46
Natrelle® breast implant accessories 47
ConfidencePlus® warranty program 49
Additional information 50
Lee
Natrelle INSPIRA® Style SRM-255
Individual results may vary.
To order breast-shaping products,
please call Customer Care at 1-800-766-0171.
1
Natrelle® Breast Implants
Important Information
INDICATIONS
Natrelle® Breast Implants are indicated for women for the following:
• Breast augmentation for women at least 22 years old for silicone-
filled implants.
Breast augmentation for women at least 18 years old for saline-
filled implants.
Breast augmentation includes primary breast augmentation to increase breast size, as well as revision surgery to correct or improve the result of a primary breast augmentation surgery.
• Breast reconstruction. Breast reconstruction includes primary reconstruction to replace breast tissue that has been removed due to cancer or trauma or that has failed to develop properly due to a severe breast abnormality. Breast reconstruction also includes revision surgery to correct or improve the result
of a primary breast reconstruction surgery.
IMPORTANT SAFETY INFORMATION
CONTRAINDICATIONS
Breast implant surgery should not be performed in:
• Women with active infection anywhere in their body.
• Women with existing cancer or precancer of their breast who have not
received adequate treatment for those conditions.
• Women who are currently pregnant or nursing.
WARNINGS
• Breast implants are not lifetime devices or necessarily a one-time surgery.
• Avoid damage during surgery: Care should be taken to avoid the use of excessive force and to minimize handling of the implant. Use care when using surgical instruments in proximity with the breast implant. For more information, please see the full Directions for Use.
PRECAUTIONS
Safety and effectiveness have not been established in patients with the following:
• Autoimmune diseases (eg, lupus and scleroderma).
• A compromised immune system (eg, currently receiving
immunosuppressive therapy).
• Planned chemotherapy following breast implant placement.
• Planned radiation therapy to the breast following breast implant placement.
• Conditions or medications that interfere with wound healing and blood clotting.
• Reduced blood supply to breast tissue.
• Clinical diagnosis of depression or other mental health disorders, including
body dysmorphic disorder and eating disorders. Please discuss any history of mental health disorders prior to surgery. Patients with a diagnosis of depression, or other mental health disorders, should wait until resolution or stabilization of these conditions prior to undergoing breast implantation surgery.
ADVERSE EVENTS
Key adverse events are reoperation, implant removal with or without replacement, implant rupture with silicone-filled implants, implant deflation with saline-filled implants, and capsular contracture Baker Grade III/IV.
Other potential adverse events that may occur with breast implant surgery
include: asymmetry, breast pain, breast/skin sensation changes, capsular calcification, delayed wound healing, hematoma, hypertrophic scarring/scarring, implant extrusion, implant malposition, implant palpability/visibility, infection, nipple complications, redness, seroma, swelling, tissue/skin necrosis, wrinkling/rippling.
For more information see the full Directions for Use at
www.allergan.com/labeling/usa.htm. To report a problem with
Natrelle® Breast Implants, please call Allergan at 1-800-433-8871.
Natrelle® Breast Implants are available by prescription only.
3
2 breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai
Intraoperative Breast Implant Sizers
Important Information
INDICATIONS
The Natrelle ® Silicone Sizer and the Allergan Saline Sizer are indicated for single use only for temporary intra-operative insertion in the surgical pocket to evaluate and assist in determining the final breast implant size/volume. The Natrelle ®
Re-sterilizable (410 and Round) Silicone Breast Implant Sizer is used during
breast augmentation or reconstruction procedures to assist the surgeon in determining the appropriate size of a breast implant to use.
IMPORTANT SAFETY INFORMATION
CONTRAINDICATIONS
All sizers are contraindicated for use as long-term breast implants or tissue expanders. The Natrelle ® Silicone Sizer and the Allergan Saline Sizer are contraindicated for multiple patient use or multiple sterilizations.
WARNINGS
Sizers are designed for temporary intra-operative use only and are NOT long-term implants. DO NOT alter, insert or attempt to repair a damaged sizer. DO NOT reuse the Natrelle ® Silicone Sizer or the Allergan Saline Sizer, which are for single use only. The Silicone Sizers may rupture and release silicone gel. Infection, necrosis, hematoma/seroma and pain may occur following any type of surgery. Minute quantities of silicone gel may diffuse through the elastomer envelope.
PRECAUTIONS
The surgeon must carefully evaluate patient suitability and be knowledgeable about the use of this device. DO NOT expose the sizer to contaminants. Avoid damaging the sizer with surgical instruments (e.g. sharp, blunt or cautery devices). DO NOT attempt to repair damaged products. DO NOT damage the sizer by overhandling, manipulation, or excessive force. Maintain a sterile back-up sizer during surgery.
ADVERSE EVENTS
Adverse events and/or complications may include sepsis, hemorrhage, thrombosis, bleeding, and/or infection.
For more information, please visit www.allergan.com/labeling/usa.htm.
To report a problem, please call Allergan at 1-800-433-8871.
Intraoperative Breast Implant Sizers are available by prescription only.
4 5
Natrelle® 133Plus and 133 Tissue
Expanders With/Without Suture Tabs
and With MAGNA-SITE® Injection Sites
Important Information
INDICATIONS
Natrelle® 133Plus and 133 Tissue Expanders are indicated for:
• Breast reconstruction following mastectomy.
• Treatment of underdeveloped breasts.
• Treatment of soft tissue deformities.
IMPORTANT SAFETY INFORMATION
CONTRAINDICATIONS
Natrelle® 133Plus and 133 Tissue Expanders SHOULD NOT be used in patients:
• Who already have implanted devices that would be affected by a magnetic field
(eg, pacemakers, drug infusion devices, artificial sensing devices).
• Whose tissue at the expansion site is determined to be unsuitable.
• Who have an active infection or a residual gross tumor at the expansion site.
• Undergoing adjuvant radiation therapy.
• Whose physiological condition (eg, sensitive over- or underlying anatomy, obesity, smoking, diabetes, autoimmune disease, hypertension, chronic lung or severe
cardiovascular disease, or osteogenesis imperfecta) or use of certain drugs
(including those that interfere with blood clotting or affect tissue viability) poses
an unduly high risk of surgical and/or postoperative complications.
• Who are psychologically unsuitable.
WARNINGS
• DO NOT use Natrelle® 133Plus and 133 Tissue Expanders in patients who
already have implanted devices that would be affected by a magnetic field
(see Contraindications), because the MAGNA-SITE® integrated injection site
contains a strong rare-earth, permanent magnet. Diagnostic testing with
Magnetic Resonance Imaging (MRI) is contraindicated in patients with Natrelle® 133Plus and 133 Tissue Expanders in place.
• DO NOT alter the tissue expander or use adulterated fill. Fill only with sterile
saline for injection as described in INSTRUCTIONS FOR USE. DO NOT expose
to contaminants.
• DO NOT expand if the pressure will compromise wound healing or vasculature
of overlying tissue, or beyond patient or tissue tolerance. Stop filling immediately
if tissue damage, wound dehiscence, abnormal skin pallor, erythema, edema,
pain, or tenderness are observed.
• Active infection anywhere may increase risk of periprosthetic infection.
Postoperative infections should be treated aggressively. Unresponsive
or necrotizing infection may require premature removal.
• Natrelle® 133Plus and 133 Tissue Expanders are temporary, single-use only
devices, and are not to be used for permanent implantation or beyond 6 months. Tissue expansion in breast reconstruction typically requires 4 months to 6 months.
• When using suturing tabs be careful to avoid piercing the shell. Use a new one
if damage occurs.
PRECAUTIONS
Active infections may need to be treated and resolved before surgery. Allergan
relies on the surgeon to know and follow proper surgical procedures and carefully evaluate patient suitability using standard practice and individual experience.
Avoid damage to the tissue expander and use a sterile backup in case of damage. Pay careful attention to tissue tolerance and hemostasis during surgery. Expansion should proceed moderately and never beyond patient or tissue tolerance. Avoid contamination in any postoperative procedure.
ADVERSE REACTIONS
Deflation, tissue damage, infection, extrusion, hematoma/seroma, capsular
contracture, premature explantation, displacement, effects on bone, pain,
sensation, distortion, inadequate tissue flap, and inflammatory reaction.
For more information, please visit www.allergan.com/labeling/usa.htm.
To report a problem with Natrelle®, please call Allergan at 1-800-433-8871.
Natrelle® 133Plus and 133 Tissue Expanders are available by prescription only.
6 7
Artistry becomes reality with the
most complete portfolio.3-5
Countless possibilities.6,‡
Inside this catalog, you will find the collection that has it all—the most complete portfolio of cohesive gel breast implants, saline-filled implants,
and tissue expanders.3-5
Our science, research, and development—the substantiating factors
in the safety of every one of our products—give us the confidence
to know that we are providing you and your patients with a high level
of satisfaction.7,8
‡Over 700 breast implant options.
Committed to supporting surgeons and patients.
Natrelle® is dedicated to offering you a full range of services for your office
and your patients. Programs such as the Natrelle® Gel Rewards Program, Brilliant Distinctions® Consumer Loyalty Program, Natrelle® ConfidencePlus®, and ALLERGAN PARTNER PRIVILEGES® are designed to support your practice and patients every step of the way. And they’re only offered from Natrelle®
and Allergan.
Natrelle® is the
#1 plastic surgery portfolio1,2,*,†
*Based on surgeon survey data, December 2016 (N = 100).
†Based on US market share data through November 2016 (N = 67).
ART. SCIENCE.
8 9
ART. SCIENCE.
Natrelle® 410
The Natrelle®
Cohesive Collection
Natrelle INSPIRA® Cohesive
Natrelle INSPIRA® Soft Touch
Natrelle INSPIRA®
Expansion meets breast shaping
Create a precise pocket for the breast shape
you both envision.
Only Natrelle® 133Plus Tissue Expanders include the
FOURTÉ™ Expander Fill System.
• FOURTÉ™ fills tissue expanders 4X faster than a 21-gauge needle9,*,†
Natrelle® 133 Tissue Expanders
• 30 years of clinical experience10
*Clinical significance has not been established.
† Methodology The FOURTÉ™ Expander Fill System and 21-gauge needle are attached to 60-cc syringes filled with water. The injector starts the injection at maximum effort while the time is tracked. When the plunger reaches the end of the syringe barrel, the time is stopped and recorded. This is repeated 20 times, recorded, and compared. 10 11
Nikki
Natrelle INSPIRA® Style SRF-415
Individual results may vary.
Natrelle INSPIRA®
Collection
12
13
Natrelle INSPIRA®
Soft Touch
Natrelle INSPIRA®
Natrelle INSPIRA Cohesive ®
Three unique silicone gels feature cross-linking technology for
3 distinct cohesivities.
Highly
Cohesive cohesive
Cohesivity Level
Cohesivity Level
Cohesivity Level
1 2 3 Cohesivity Level
Cohesivity Level
Cohesivity Level
1 2 3
Cohesivity Level
Cohesivity Level
1 2 3
55%
more cohesive
than level 111,†
Natrelle INSPIRA®
SMOOTH ROUND GEL IMPLANTS
STYLES SCX, SSX, & SRX EXTRA-FULL PROFILE
Low Low Plus Moderate Full eXtra-Full
Smooth
Cohesive
(SCX)
Smooth
Soft Touch
All Natrelle INSPIRA® Round Gel Breast Implants offer:
• Systematic diameter sizing for simplified implant selection
• Smooth or BIOCELL® textured surface
• 5 projection style options
• Matching sizers available
Natrelle® offers the widest range of cohesivities for every
breast, patient type, and aesthetic vision—whether it’s
Three cohesivities. for reconstruction, revision, or augmentation.11
Countless possibilities.6,*
*Over 700 breast implant options.
† Methodology Breast implant gel was measured for material properties using the BTC-2000 ™.
The BTC-2000 ™ applies a controlled vacuum, or negative pressure, to the gel while measuring the
dynamic response of material deformation using a synchronized target laser. The gel for each device
(n = 8 per group) was tested at 3 sites, all at or near the apex of the implant (anterior side). From
those measurements, the gel cohesivity was calculated and the relative change was determined.
Natrelle INSPIRA®
Collection
14 15 16
Natrelle INSPIRA®
SMOOTH ROUND GEL IMPLANTS
STYLES SCM, SSM, & SRM MODERATE PROFILE
Low Low Plus Moderate Full eXtra-Full
Smooth
Cohesive
(SCM)
Smooth
Soft Touch
(SSM)
Smooth
INSPIRA
(SRM)
Volume
(cc)
Diameter
(cm)
Projection
(cm)
SMOOTH ROUND GEL IMPLANTS
STYLES SCL, SSL, & SRL LOW PROFILE
Low Low Plus Moderate Full eXtra-Full
Smooth
Cohesive
(SCL)
Smooth
Soft Touch
(SSL)
Smooth
INSPIRA
(SRL)
Volume
(cc)
Diameter
(cm)
Projection
(cm)
TEXTURED ROUND GEL IMPLANTS
17 18 19 20
Natrelle ® 410 Style FM
Individual results may vary.
Natrelle ® 410
Anatomical Gel
21 22 23
Natrelle ® 410
ANATOMICAL GEL IMPLANTS
STYLE FX
FULL HEIGHT/EXTRA-FULL PROJECTION
Catalog
Number
Volume
(cc)
Width
(cm)
Height
(cm) (cm)breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubaiRe-sterilizable
Sizer
MX-410165 MSZLX625Cohesivity LevelCohesivity LevelCohesivity Level123
Designed to mirror the curve of a woman’s breast.
Natrelle® 410 Anatomical Gel Breast Implants are filled with highly cohesive silicone gel and are designed to maintain their shape over time.
Natrelle ® 410 Anatomical Gel Breast Implants have the most
high-projection (≥ 6.0 cm) sizes available.3-5
Natrelle® 410 Anatomical Gel Breast Implants offer:
• Shaped fullness
• Highly cohesive gel
• BIOCELL® textured surface
• 4 projection style options
• Matching sizers available
Natrelle ® 410
Anatomical Gel
Breast Implants
MMLMModerate ProjectionMXFXLXMFFFFMLFFLMLLLFull HeightModerate HeightLow HeightLow ProjectionFull ProjectioneXtra-Full Projection
116 size options3
Offering the highest-projection implant—7.1 cm—in all 3 heights.3-5
Natrelle ® 410
Anatomical Gel
25 26
24
STYLE LF
LOW HEIGHT/FULL PROJECTION
Catalog
Number
Volume
(cc)
Width
(cm)
Height
(cm)
Projection
(cm)
Re-sterilizable
Sizer
LF-410125
125
9.5
7.6
3.7
MSZLF125
LF-410150
150 10.2
4.4
10.0 15.0 350-370 468-230 10.2 11.9 Paired for precision
Natrelle® 133Plus delivers a seamless match
between tissue expander and round breast implant.
• 100% match (in base width and projection) to Natrelle INSPIRA®12,†
• 83% match (in base width and projection) to Natrelle ® 41012,†
Only Natrelle ® 133Plus
Tissue Expanders
include the FOURTÉ™
Expander Fill System
• Patented 4-needle design fills tissue expanders
4X faster than a standard 21-gauge needle9,‡,§
• May save up to 9 minutes of expander fill time9,‡,§
Building on the success of the
original Natrelle® 133—
the #1 surgeon-selected tissue expander.2,*
Blue tabs designed for suture accuracy.
FOURTÉ™ Expander Fill System
Blue orientation line assists in precise placement within the breast pocket.
*Based on US market share data through November 2016 (N = 67).
Natrelle ® 133Plus
Tissue Expanders
36
37
WARNING: The strong rare-earth, permanent magnet contained in the Natrelle ® Style 133Plus Series Tissue Expanders is contraindicated where the magnetic field may affect other polarized devices
(eg, pacemakers, drug infusion devices, artificial sensing devices, similar-type products, and
MRI procedures).
NOTE: All Natrelle ® 133Plus Tissue Expanders include the FOURTÉ™ Expander Fill System.
STYLE 133P-FX
FULL HEIGHT/
EXTRA PROJECTION
Catalog Number
Volume
(cc)
Width
39
Jessica
Natrelle ® 133 Style MV, 400 cc
Natrelle ® 410 Style FF, 425 cc
Individual results may vary.
Natrelle ® 133
Tissue Expanders
40
41
Natrelle ® 133
Tissue Expanders
Natrelle ® 133 Tissue Expanders offer a precise match with Natrelle ® breast implants.
All Natrelle ® 133 Tissue Expanders offer:
• 84 options with or without suture tabs3
• BIOCELL® textured surface
• 7 style options
*Based on US market share data through November 2016 (N = 67).
#1 surgeon-selected tissue expander with 30 years of clinical experience.2,10,*
Natrelle ® 133
Tissue Expanders
43
WARNING: The strong rare-earth, permanent magnet contained in the Natrelle ® Style 133 Series Tissue Expanders is contraindicated where the magnetic field may affect other polarized devices
(eg, pacemakers, drug infusion devices, artificial sensing devices, similar-type products, and
MRI procedures). breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai
44
45
FOURTÉ™ Expander Fill System
Description
Catalog Number
Four-pronged 21-gauge, 1¾” butterfly needles, tubing, luer adapter
F-4444
Natrelle ®
tissue expander accessories
Natrelle®
breast implant accessories
Sizer Templates
Description
Catalog Number
Plastic measuring templates for Styles 133Plus and 133 Tissue Expanders, nonsterile:
Styles 133P-FX and 133FX Sizer Template Set
30-00038
Styles 133P-FV and 133FV Sizer Template Set
30-00018
Styles 133P-MX and 133MX Sizer Template Set
30-00039
Styles 133P-MV and 133MV Sizer Template Set
30-00017
Styles 133P-SX and 133SX Sizer Template Set
30-00040
Styles 133P-SV and 133SV Sizer Template Set breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai
30-00035
Styles 133P-LV and 133LV Sizer Template Set
30-00016
MAGNA-FINDER® Xact Port Finders
Description
Catalog Number
Xact2
External locating device with dermal indicator for use with Style 133Plus Tissue Expanders for locating MAGNA-SITE® injection sites (provided nonsterile)
30-00034
Xact
External locating device for use with Style 133 Tissue Expanders for locating MAGNA-SITE® injection sites (provided nonsterile)
30-00032
21-G Needle Infusion Set
Description
Catalog Number
21-gauge, 1¾” butterfly needle, tubing, luer adapter
30-00012
Universal Fill Kit
Description
Catalog Number
60-cc syringe, 122-cm transfer set with piercing
device, 25-cm extension tube, 2-way check valve
30-00033
Diaphragm Valve Fill Tube and Reflux Valve
Description
Catalog Number
Diaphragm valve fill tube and reflux valve
25-00017
BIOCELL® Delivery Assistance Sleeve
Description
Catalog Number
Clear, sterile sleeve
27-000001
The above accessories are not eligible for return for credit.
The above accessories are not eligible for return for credit.
Accessories
47
46
Warranty program brochure
ConfidencePlus®
warranty program
Get more coverage and confidence with Natrelle ® Gel implants than with any other breast implant warranty—
ONLY with Natrelle ® ConfidencePlus ®.
• The ONLY warranty with a 10-year FREE breast implant replacement
in the event of capsular contracture (Baker Grade III/IV)
• The ONLY warranty to cover primary AND revision surgeries in the
event of capsular contracture (Baker Grade III/IV)
• The ONLY warranty that allows you to choose ANY style and size of
Natrelle® Gel breast implant for replacement in the event of capsular contracture (Baker Grade III/IV) or rupture
• Lifetime product replacement for all gel implants in the event of rupture
• Financial assistance up to $3500 for 10 years in the event of
implant rupture
For more information about the ConfidencePlus ® warranty program, please visit Natrelle.com/warranty.
Accessories
Warranty Program
48
49
Additional information
CAUTION: United States Federal Law restricts these devices to sale
by, or on the order of, a licensed physician.
PRODUCT SUPPLIED STERILE: Please see Directions for Use at
www.allergan.com/labeling/usa.htm for additional product information
including warnings, precautions, adverse reactions, and instructions for
use. Natrelle ® Styles 133Plus and 133 Tissue Expander Sizing
Templates and MAGNA-FINDER® breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai Xact2 and Xact are supplied nonsterile.
DIMENSIONS: Dimensions listed are typical and are measured with the
implant placed on a flat surface. Not every implant will conform to the dimensions given. Slight variations may occur.
RECOMMENDED FILL VOLUMES: Following recommended fill volumes
for saline-filled breast implants can decrease t breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai he possibility of shell
wrinkling and crease-fold failure.13
Committed to advancing the field of breast aesthetics.
We have advanced the medical aesthetics industry through scientific discovery, market innovation, and partnering with the medical
communities that we serve.
Building on 50 years of scientific research and development, we are
taking our passion for innovation and applying it to the consumer realm. That’s why we’ve created the Natrelle ® Portfolio—specially designed
to give you and your patients more options to help you achieve the
desired results.
Additional Information
Warranty Program
50
51
ART. SCIENCE.
Shaping the future with you
Natrelle® is the #1 plastic surgery portfolio.1,2,*,†
Natrelle INSPIRA® Collection
#1 selected round gel implant collection in the US.1,*
Natrelle ® 410
#1 selected anatomically shaped implant in the US.2,†
Natrelle® 133 Series
#1 selected tissue expander in the US.2,†
Natrelle INSPIRA® Cohesive
Most cohesive round gel breast implant in the US.11
*Based on surgeon survey data, December 2016 (N = 100).
†Based on US market share data through November 2016 (N = 67).
To order breast aesthetics products,
please call Customer Care at 1-800-766-0171.
© 2017 Allergan. All rights reserved. All trademarks are the property of their respective owners.
Natrelle.com NAT64504_v2 03/17 170324
References:
1. Data on file, Allergan, December 2016; Plastic Surgery Monthly Tracker: Breast Implants & Tissue Expanders.
2. Data on file, Allergan, November 2016; Breast Implant + Tissue Expander Share Tracker. 3. More of Everything: Natrelle® Product Catalog. Irvine, CA: Allergan; 2015. 4. Our products: breast implants. Mentor Worldwide LLC website. http://www.mentorwwllc.com/global-us/Breast.aspx. Updated April 2016. Accessed February 14, 2017. 5. Sientra® HSC & HSC + Breast Implant Product Catalog. Santa Barbara, CA: Sientra, Inc., 2015. http://sientra.com/Content/pdfs
/MDC-0177%20R2%20HSCHSC%2B%20Breast%20Implants%20Product%20Catalog.pdf. Accessed February 14, 2017. 6. Data on file, Allergan, January 2017; Allergan Plastic Surgery Order Form. 7. Natrelle® Silicone-Filled
Breast Implants and Natrelle INSPIRA® Breast Implants: Smooth & BIOCELL® Texture Directions for Use, 2016.
8. Natrelle® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants Directions for Use, 2014.
9. Data on file, Allergan, January 4, 2016; Protocol MM-1225-FR. 10. Data on file, Allergan, July 14, 1986; FDA Section 510(k) marketing approval letter. 11. Data on file, Allergan, February 8, 2017; Study Report MD16075-DV2. 12. Data on file, Allergan, January 6, 2017; Study Report MD16076-DV. 13. Natrelle ® Saline-Filled Breast Implants: Smooth & BIOCELL® Texture Directions for Use, 2014.
Additional Information
Founded in 1979, Nagor™ is the only British
company dedicated to the specialist design,
manufacture and supply of high quality
breast implants and related medical devices.
Nagor’s commitment to quality is demonstrated
by ongoing research and development with
investment in manufacturing processes,
supported by the most demanding quality
control management.
Nagor’s products are manufactured under a
quality management system in accordance
with EN ISO 13485 and products intended for
sale in Europe are CE certified according to the
applicable European medical device regulations.
All dimensions and weights are approximate and slight variations
may occur between the product catalogue and the product label.
4 5
Introduction to
Breast Aesthetics
Shapes
• Round: Impleo™
• Anatomical: CoGel™
SiloGard™ 360° Barrier Layer
All Nagor™ implants are manufactured with high performance
silicone elastomer layers to enhance shell integrity and have
a unique SiloGard™ 360° barrier layer to minimise gel diffusion.
Shell surface
• Smooth
• Nagotex® mid-textured
SiloGel Twist™
6th generation soft form stable high cohesive silicone gel.
GCA comfort guarantee
Lifetime product replacement warranty, for details view our
brochure.
Instructions for use
We encourage surgeons to refer to the package insert supplied
with every Nagor® product for instructions for use, indications
and contraindications.
Round Silicone Gel-Filled implants
Anatomical Silicone Gel-Filled implants
Profile Moderate High Extra High
Textured Surface Soft Form Stable
High Cohesive Gel 100% Fill
IMP-MR IMP-HR IMP-EHR
Smooth Surface Soft Form Stable
High Cohesive Gel 100% Fill
IMP-SMR IMP-SHR IMP-SEHR
CoGel® System Low Moderate High
Full Height XF1 XF2 XF3
Moderate Height XM1 XM2 XM3
Low Height XL1 XL2 XL3
Breast Aesthetics
6
Nagotex® Mid-textured Surface.
Tapered edges for less visibility and palpability.
Firm upper pole for shape maintenance.
Higher projection for added lift.
SiloGard™ 360° Barrier.
SiloGel™ form stable high cohesive gel.
7 Orientation marker dots.
Gel-filled and Inflatable Sizers available for core sizes.
XF1
(F) Full Height
(1) Low Projection
XM1
(M) Moderate Height
(1) Low Projection
XL1
(L) Low Height
(1) Low Projection
XL2
(L) Low Height
(2) Moderate Projection
XL3
(L) Low Height
(3) High Projection
XM2
(M) Moderate Height
(2) Moderate Projection
XM3
(M) Moderate Height
(3) High Projection
XF2breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai(F) Full Height
(2) Moderate Projection
XF3
(F) Full Height
(3) High Projection
Greater Precision for Individualised
Augmentation.
7
WIDTH / HEIGHT
W
H
LVC
P
A
PROJECTION / ARC
IMPLANT CATALOGUE
MENTOR® BREAST IMPLANTS
© Mentor Worldwide LLC 2018 062724-161103
F RO N T PA G E F I N I S H E S S H O R T
In 2002, we completed a plant in Leiden, The Netherlands.
At 6,000 square meters, it is one of the largest of its
kind in the world. This plant contains an automated
breast implant dipping machine, which produces
every implant shell in a consistently uniform
manner. To meet an ever-increasing demand
for our products, plant produces more
than 300,000 breast implants a
year, distributed to more than
100 nations. At Mentor all
our products are made
under strict standards
of design and
testing.
F RO N T PA G E F I N I S H E S S H O R T
F RO N T PA G E F I N I S H E S S H O R T
Founded in 1969, Mentor Worldwide LLC is a leading
manufacturer and supplier of medical products for the
global Aesthetic medicine market and Reconstructive
surgery. As the world’s leading maker of high-quality
breast implants for over 30 years, our experience results
in quality products that you can rely on.
Headquartered in Irvine, California, Mentor has
manufacturing and research operations in the United
States and the Netherlands. In 1995, Mentor became the
first breast implant manufacturer to achieve CE-marking
for its products.
Mentor has worked closely with surgeons throughout
the world to develop innovative products such as
MENTOR® CONTOUR PROFILE™ BECKER™ 35 Expander/
Breast Implant and the MENTOR® CPG™ breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai Gel Breast
Implants.
Mentor’s manufacturing capability is exceptional.
We have substantial experience in biomaterials and
biopolymers manufacturing. At the same time, our
regulatory expertise has enabled the Company to bring
products to market in the world’s most stringently
regulated health care environments.
Mentor is a manufacturer with a strong customer focus.
Our sales representatives are skilled in technical product
issues, enabling them to act as a valuable information
F RO N T PA G E F I N I S H E S S H O R T
resource. For questions or
additional information, please
contact your local Mentor
branch, Johnson & Johnson
office or distributor.
On Jan 23, 2009, Mentor
was acquired by Johnson &
Johnson, one of the leading
providers of suture, mesh,
hemostats and other products
for a wide range of surgical
procedures. By joining forces,
we aspire to be the trusted
global leader in aesthetic
medicine among both
consumers and professionals
by providing a broad range
of innovative, science and
clinical-based solutions
to maintain, enhance, and
restore self-esteem and quality
of life. Simply said, our goal is
to make life more beautiful.
F RO N T PA G E F I N I S H E S S H O R T
A More Evolved Implant
MemoryGel™
BREAST IMPLANTS
About MemoryGel™ Implants
MENTOR® MemoryGel™ Breast Implants feature a
proprietary cohesive silicone gel formulation used to fill all
MENTOR® Silicone Gel-Filled Breast Implants around the
world. By varying the components of the gel, Mentor is able
to produce a wide selection of products ranging from very
soft to very firm.
• Strict US and EU manufacturing standards
• Highly compliant shell for ease of placement
• Lifetime product replacement policy
• MENTORPromise Protection Plan, the most comprehensive
protection plan available1
• Moderate Plus, Xtra Moderate Plus, High, Xtra High and Ultra
High projection
• Proprietary silicone gel formula for a natural touch that
resembles breast tissue
F RO N T PA G E F I N I S H E S S H O R T
MemoryGel™ Breast Implants
MemoryGel™ Breast Implants Product Scale
Product Profile Cohesive I™ Cohesive II™ Cohesive III™
Round Moderate Plus
Memory GelTM Xtra Moderate Plus
Round High
Memory GelTM Xtra High
Round Ultra High
CPGTM Gel Breast Implant
Round BECKERTM 25
Expander/ Breast Implant
CONTOUR PROFILETM BECKER™
Expander/ Breast Implant 35
F RO N T PA G E F I N I S H E S S H O R T
All MENTOR® Silicone Gel-Filled Breast Implants contain
gel that is cohesive, safe and aesthetically pleasing’.
Cohesive I™
The standard cohesive level gel used in Mentor® Breast Implants.
This is the softest gel and has been preferred by millions of women
worldwide. Products are available textured and smooth Moderate Plus,
Xtra Moderate Plus, High, Xtra High and Ultra High projection Gel Breast
Implants as well as the MENTOR® Becker™ Expander/Breast Implants.
Cohesive II™
A slightly firmer gel, for surgeons wanting a firmer feeling implant.
This gel is used in textured Moderate Plus, High Profile Gel Breast
Implants and MENTOR® Contour Profile™ Becker™ Expander/Breast
Implants.
Cohesive III™
Mentor’s most cohesive gel, providing shape retention with a
pleasing level of firmness for optimal aesthetic results. This gel is
used in the Mentor® CPG™ Gel Breast Implants.
All Cohesive, all the time.™
Advanced MemoryGel™ Breast Implants.
The more evolved implant.
F RO N T PA G E F I N I S H E S S H O R T
PROVEN
TEXTURE YOU
CAN TRUST
MENTOR® CPG™ Implants are proven to have a low risk of capsular
contracture and rotation in primary augmentation patients at 10 years
and are covered by the most comprehensive warranty in the market.2
Not a head to head study. Based on the comparison of key complication rates reported in the 10 year Core
Studies for MemoryShape®/ CPG™ Gel Breast Implants, NATRELLE™ 410 TruForm™ 3 Gel Breast Implants.
*Specification for MemoryGel™ Round Gel implants
The third-party trademarks used herein are trademarks of their respective owners.
MENTOR®:
SILTEX™ Texture3*
Allergan®:
Biocell Texturing3
Surface
Description
Manufacturing
Technique
Pore Size
Width (μm)
Pore Size Depth/
Height (μm)
Edge(μm)
Distribution
Depression
or Nodules
Gentle patterned
surface
Aggressive, open-pored
surface with cuboid-shape
depressions and a stilted edge
Negative contact
imprint off polyurethane
texturing foam
Shell is pressed onto bed
of finely granular salt: lost
salt technique
70-150 600-800
40-100 (height) 100-150 (depth)
0 100-150
Regular Irregular
Nodules Depressions
F RO N T PA G E F I N I S H E S S H O R T
PROVEN
PERFORMANCE
Reliable implants continuously delivering world class clinical results.
The lowest reported risk of key complications in primary
breast augmentation for MENTOR® CPG™ Gel Breast
Implants at 10 years2
Primary
Augmentation
MENTOR®CPG Breast
Implant Core Study,
Long Term 10 years4
Allergan® Natrelle® Breast
Implant Core Study, Long
Term 10 years5,6
Capsular Contracture
(Baker III/IV)
Suspected or Confirmed
Rupture (MRI Cohort)
Device Removal
(with or without replacement)
Rotation
3.6%
6.6%
9.2%
1.3%
9.2%
17.7%
19.6%
4.7%
Kaplan-Meier estimated risk of first occurrence. Data presented in table is
not based on a head to head comparison of the Mentor® CPG™ Gel Breast
Implant and the Allergan® Natrelle® 410 Breast Implant Core Studies.
F RO N T PA G E F I N I S H E S S H O R T
8080 PERSON YEARS OF
FOLLOW UP DATA
43 SITES
955
SUBJECTS
Multi-center Core Study
F RO N T PA G E F I N I S H E S S H O R T
PROVEN
PEACE of MIND
To our Mentor customers and patients, we pledge our commitment
to excellence. That is why we back our MemoryGelTM Breast Implants
with the most comprehensive plan in the industry.
Mentor Warranties & Product Replacement Policy
† In the event of a confirmed rupture or deflation (leaking) of any MENTOR® Breast Implant due to wear or delamination requiring
surgical intervention, regardless of the age of the implant, Mentor will provide a free replacement of a MENTOR® Breast Implant of
any size in the same or similar style as the originally implanted product.
α When a replacement surgery of a MENTOR® Gel-Filled Breast Implant is required due to confirmed rupture occurs within ten
(10) years from the date of implantation, provided that eligibility is proven and confirmed by Mentor based on its assessment and
evaluation, Mentor will pay uninsured, out-of-pocket costs for operating room, anesthesia and/or surgical expenses directly related
to revision surgery up to a maximum aggregate amount of €1000. Operating room and anesthesia charges shall be given payment
priority. In such cases, the request for financial assistance under the MentorPromise Protection Plan must be made to your surgeon.
Financial assistance does not imply a loan to you.
β In the events of capsular contracture (Baker III/IV), double capsule or late-stage seroma in augmentation surgery of a MENTOR®
Gel-Filled Breast Implant, Mentor will provide a replacement of a MENTOR® Gel-Filled Breast Implant, free of charge for the period
of ten (10) years from the date of implantation, provided that eligibility is proven and confirmed by Mentor based on its evaluation of
explanted product and assessment of all required documentation. Mentor will provide a replacement MENTOR® Product of any size in
the same or similar style as the originally implanted product.
For further information about MENTOR® CPG™ Breast Implants or any other
MENTOR® Products, talk to your Mentor sales representative today or visit
mentorwwllc.eu
$
10
YEAR
FREE AND AUTOMATIC
ENROLLMENT
MENTORPromise Protection Plan Overview
FREE CONTRALATERAL
IMPLANT at your surgeon’s
request
FREE PRODUCT REPLACEMENT
IN THE EVENTS OF CAPSULAR
CONTRACTURE (Baker III/IV),
DOUBLE CAPSULE AND LATE
STAGE SEROMAβ
UP TO €1000 FINANCIAL
ASSISTANCE COVERAGE
FOR RUPTUREα
FREE LIFETIME PRODUCT
REPLACEMENT FOR
RUPTURE†
F RO N T PA G E F I N I S H E S S H O R T
Uncover the unique SILTEXTM Texture of MENTOR® CPGTM Gel
Breast Implants today. Talk to your Mentor Sales Representative
or visit mentorwwllc.eu for more information.
A closer look at MENTOR® patented SILTEX™ Texture
SEM images of SILTEXTM Texture
Anterior View Radius View Posterior View Cross Section View
SILTEX™ Texture providing
you and your patients with
peace of mind.
F RO N T PA G E F I N I S H E S S H O R T
RIGHT FROM THE
START. MADE TO
MATCH
Expansion matters. Texture you can trust.
Natural shape
Presenting the:
CPX™4 Breast Tissue Expander and CPG ™ Gel Breast Implants, giving you
greater control over the desired shape in two stage breast reconstruction:
1. MENTOR® is the only company to offer a breast tissue expander with
proven directional lower pole expansion7
2. CPG Implants can help achieve a smooth transition from tissue to implant8
3. Unsurpassed Peace of Mind
F RO N T PA G E F I N I S H E S S H O R T
γ The third-party trademarks used hereibreast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai are trademarks of their respective owners
CPX™4 Breast
Tissue Expander
Post operatively adjustable device
PATIENT COMFORT
Incorporates two principle innovations
that were designed to enhance patient
comfort while maintaining the same
expansion profile9
TEXTURED SURFACE
The patented SILTEXTM Texture
has a surface substantially free of
pores and interstices
The manufacturing process for the
SILTEXTM Texture on MENTOR®
Breast Tissue Expanders does not
require the use of salt or sugar
crystals.
EASY TO DETECT
The CENTERSCOPE® Magnetic
Detection Device locates
the magnetic injection dome
for absolute ease and acuracy.
The injection dome contains
a rare earth magnet that is
48% stronger than previous
expanders9
NATURAL SHAPE
The Combination of the Buffer-
ZoneTM Self-Sealing Patch and
the posterior Dacron® Patch
provides directionally focused
expansion to maximize lower
pole expansion to mimic the
shape of a natural breast γ
F RO N T PA G E F I N I S H E S S H O R T
F RO N T PA G E F I N I S H E S S H O R T
MENTOR®
MemoryGel™ Xtra
Breast Implants
She’s confident in what she wants - An innovation in
breast implants from the brand you trust.
Soft, Natural
Feelδ10
Xtra
Fullness11
Xtra
Firmness11
Xtra
Projection11
δ In-person consumer survey with 452 respondents.
F RO N T PA G E F I N I S H E S S H O R T
F RO N T PA G E F I N I S H E S S H O R T
Round
Expanders
Other
CPG
Siltex™ Round Breast Implants, Cohesive ITM
Smooth Round Breast Implants, Cohesive ITM
Siltex™ and Smooth MemoryGel™ Xtra Breast Implants
Siltex™ Round Breast Implants, Cohesive IITM
CONTOUR PROFILE™ Tissue Expanders
BECKER™ Expander/Breast Implants
Other Expanders
Accessories
Saline products
Sizers
CPG™ Gel Breast Implants, Cohesive III™
F RO N T PA G E F I N I S H E S S H O R T
Round
SILTEX™ Round Breast Implants,
Moderate Plus Profile, Cohesive ITM
Vol
cc
Diameter
cm
Proj
cm Catalog #
Resterilizable
Gel Sizerε
Round Gel Breast Implants,
Cohesive I™
- 2 -
ε Resterilizable up to 10 times.
Round
Round Gel Breast Implants,
Cohesive I™
SILTEX™ Round Breast Implants,
High Profile, Cohesive I™
Vol
cc
Diameter
cm
Proj
cm Catalog #
Resterilizable
Gel Sizerε
ε Resterilizable up to 10 times.
Round
Round Gel Breast Implants,
Cohesive I™
SILTEX™ Round Breast Implants,
Ultra High Profile, Cohesive I™
Vol
cc
Diameter
cm
Proj
cm Catalog #
Resterilizable
Gel Sizerε
- 4 -
ε Resterilizable up to 10 times.
Round
Round Gel Breast Implants,
Cohesive I™
- 5 -
Round
Round Gel Breast Implants,
Cohesive I™
Smooth Round Breast Implants,
Moderate Plus Profile, Cohesive I™
Vol
cc
Diameter
cm
Proj
cm Catalog #
Resterilizable
Gel Sizerε
ε Resterilizable up to 10 times.
Round
Round Gel Breast Implants,
Cohesive I™
Smooth Round Breast Implants,
High Profile, Cohesive I™
Vol
cc
Diameter
cm
Proj
cm Catalog #
Resterilizable
Gel Sizerε
ε Resterilizable up to 10 times.
Round
Round Gel Breast Implants,
Cohesive I™
Smooth Round Breast Implants,
Ultra High Profile, Cohesive I™
Vol
cc
Diameter
cm
Proj
cm Catalog #
Resterilizable
Gel Sizerε
ε Resterilizable up to 10 times.
Round
- 9 -
Round Gel Breast Implants,
Cohesive I™
Round
SILTEX™ Round Moderate Plus
Profile Xtra Gel Breast Implants
Vol
cc
Diameter
cm
Proj
cm Catalog #
Resterilizable
Gel Sizerε
- 10 -
MemoryGelTM Xtra Breast Implants
ε Resterilizable up to 10 times.
Round
- 11 -
MemoryGelTM Xtra Breast Implants
SILTEX™ Round High Profile
Xtra Gel Breast Implant
Vol
cc
Diameter
cm
Proj
cm Catalog # breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai
Resterilizable
Gel Sizerε
150 8,4 4,2 THPX-150 RSZTHPX150
175 9,0 4,4 THPX-175 RSZTHPX175
200 9,4 4,5 THPX-200 RSZTHPX200
230 9,8 4,8 THPX-230 RSZTHPX230
255 10,1 4,9 THPX-255 RSZTHPX255
285 10,5 5,1 THPX-285 RSZTHPX285
325 10,8 5,4 THPX-325 RSZTHPX325
340 11,1 5,4 THPX-340 RSZTHPX340
365 11,4 5,5 THPX-365 RSZTHPX365
405 11,6 5,9 THPX-405 RSZTHPX405
425 11,9 5,8 THPX-425 RSZTHPX425
455 12,1 6,0 THPX-455 RSZTHPX455
470 12,3 5,9 THPX-470 RSZTHPX470
515 12,6 6,2 THPX-515 RSZTHPX515
570 13,2 6,3 THPX-570 RSZTHPX570
620 13,4 6,5 THPX-620 RSZTHPX620
680 14,0 6,6 THPX-680 RSZTHPX680
725 14,5 6,7 THPX-725 RSZTHPX725
765 14,7 6,7 THPX-765 RSZTHPX765
ε Resterilizable up to 10 times.
Round
- 12 - MemoryGelTM Xtra Breast Implants
Smooth Round Moderate Plus
Profile Xtra Gel Breast Implant
Vol
cc
Diameter
cm
Proj
cm Catalog #
Resterilizable
Gel Sizerε
ε Resterilizable up to 10 times.
Round
MemoryGelTM Xtra Breast Implants
Smooth Round High Profile
Xtra Gel Breast Implant
Vol
cc
Diameter
cm
Proj
cm Catalog #
Resterilizable
Gel Sizerε
ε Resterilizable up to 10 times.
Round
Round Gel Breast Implants,
Cohesive II™
SILTEX™ Round Breast Implants,
Moderate Plus Profile, Cohesive II™
Vol
cc
Diameter
cm
Proj
cm Catalog #
Resterilizable
Gel Sizerε
ε Resterilizable up to 10 times.
Round
Round Gel Breast Implants,
Cohesive II™
SILTEX™ Round Breast Implants,
High Profile, Cohesive II™
Vol
cc
Diameter
cm
Proj
cm Catalog #
Resterilizable
Gel Sizerε
ε Resterilizable up to 10 times.
Round
- 16 -
CPG
MENTOR® CPG™ Gel Breast Implants,
Cohesive III™
Diagrams not to scale, for reference only.
LOWER POLE ARC (LPA) =
Length measured along
the lower pole of the
implant running from the
bottom of the implant
(Point B) upto the midway
point (Point A) including a
0,5 cm of tissue thickness.
MIDWAY POINT
HEIGHT
LOWER POLE ARC
MEASUREMENT ASSUMES
0,5 CM OF TISSUE THICKNESS
50%
50%
0,5 cm
MENTOR® CPG™ BREAST IMPLANT
NAMING LEGEND
Cohesive Level Implant Height Implant Projection
III
3
Tall
3
Medium
2
Low
1
High
3
Moderate Plus
2
Moderate
1
KEY: DIGIT 1 = COHESIVE LEVEL
DIGIT 2 = HEIGHT OF IMPLANT
DIGIT 3 = PROJECTION OF IMPLANT
UNDERSTANDING THE
LOWER POLE ARC
- 17 -
CPG
CPG™ Gel Breast Implants,
Cohesive III™
Vol
cc
Width
cm
Height
cm
Projection
cm
Lower
Pole Arc
A-B cm Catalog #
Resterilizable
Gel Sizerε
CPG™ Implants 331, Cohesive III™,
Tall Height, Moderate Projection
Vol
cc
Width
cm
Height
cm
Projection
cm
Lower
Pole Arc
A-B cm Catalog #
Resterilizable
Gel Sizerε
CPG™ Implants 321, Cohesive III™,
Medium Height, Moderate Projection
ε Resterilizable up to 10 times.
- 18 -
CPG
CPG™ Gel Breast Implants,
Cohesive III™
Vol
cc
Width
cm
Height
cm
Projection
cm
Lower
Pole Arc
A-B cm Catalog #
Resterilizable
Gel Sizerε
CPG™ Implants 311, Cohesive III™,
Low Height, Moderate Projection
- 19 -
ε Resterilizable up to 10 times.
CPG
CPG™ Gel Breast Implants,
Cohesive III™
CPG™ Implants 322, Cohesive III™,
Medium Height, Moderate Plus Projection
Vol
cc
Width
cm
Height
cm
Projection
cm
Lower
Pole Arc
A-B cm Catalog #
Resterilizable
Gel Sizerε
- 20 -
Vol
cc
Width
cm
Height
cm
Projection
cm
Lower
Pole Arc
A-B cm Catalog #
Resterilizable
Gel Sizerε
CPG™ Implants 332, Cohesive III™,
Tall Height, Moderate Plus Projection
ε Resterilizable up to 10 times.
CPG
Vol
cc
Width
cm
Height
cm
Projection
cm
Lower
Pole Arc
A-B cm Catalog #
Resterilizable
Gel Sizerε
CPG™ Implants 312, Cohesive III™,
Low Height, Moderate Plus Projection
CPG™ Gel Breast Implants,
Cohesive III™
- 21 -
ε Resterilizable up to 10 times.
CPG
CPG™ Gel Breast Implants,
Cohesive III™
- 22 -
Vol
cc
Width
cm
Height
cm
Projection
cm
Lower
Pole Arc
A-B cm Catalog #
Resterilizable
Gel Sizerε
CPG™ Implants 323, Cohesive III™,
Medium Height, High Projection
Vol
cc
Width
cm
Height
cm
Projection
cm
Lower
breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai
CPG
Vol
cc
Width
cm
Height
cm
Projection
cm
Lower
Pole Arc
A-B cm Catalog #
Resterilizable
Gel Sizerε
CPG™ Implants 313, Cohesive III™,
Low Height, High Projection
CPG™ Gel Breast Implants,
Cohesive III™
- 23 -
ε Resterilizable up to 10 times.
CPG
MENTOR® CONTOUR PROFILE™ Breast Tissue
Expanders / CPG™ Gel Breast Implants
Sizing Guide / Two-Stage Breast Reconstruction
STAGE 1
Selection of the CPX4™Expander
Styles 9100 – Low Height
Volume
cc
Width
cm
Height
cm
Proj.
cm Catalog #
CPG™ Implant 311
Cohesive III™, Low Height, Moderate Projection
Volume
cc
Width
cm
Height
cm
Proj.
cm Catalog #
180 11,0 9,8 3,7 334-1101
210 11,5 10,3 3,9 334-1151
270 12,5 11,2 4,2 334-1251
300 13,0 11,6 4,4 334-1301
375 14,0 12,5 4,7 334-1401
460 15,0 13,4 5,1 334-1501
510 15,5 13,8 5,2 334-1551
560 16,0 14,3 5,4 334-1601
615 16,5 14,7 5,6 334-1651
CPG™ Implant 311
Cohesive III™, Low Height, Moderate Projection
Volume
cc
Width
cm
Height
cm
Proj.
cm Catalog #
Styles 9200 – Medium Height
Volume
cc
breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai
cm Catalog #
- 24 -
CPG
*PLEASE NOTE: The CONTOUR PROFILE™ Tissue Expander Injection Dome is not MRI compatible. For
detailed indications, contraindications, warning and precautions associated with the use of this device,
please refer to the Product Insert Data Sheet. Individual implant dimensions may vary slightly in
products of this type. Not all units conform exactly to the dimensions noted.
CPG™ Implant 312
Cohesive III™, Low Height, Moderate Plus Projection
Volume
cc
Width
cm
Height
cm
Proj.
cm Catalog #
CPG™ Implant 313
Cohesive III™, Low Height, High Projection
Volume
cc
Width
cm
Height
cm
Proj.
cm Catalog #
Selection of CPG™ Gel Breast Implant to use as a long-term implant after
expansion is complete.
STAGE 2
- 25 -
CPG™ Implant 312
Cohesive III™, Low Height, Moderate Plus Projection
Volume
cc
Width
cm
Height
cm
Proj.
cm Catalog #
CPG™ Implant 313
Cohesive III™, Low Height, High Projection
Volume
cc
Width
cm
Height
cm
breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai
Height
cm
Proj.
cm Catalog #
Styles 9300 – Tall Height
Volume
cc
Width
cm
Height
cm
Proj.
cm Catalog #
250 10,1 10,7 5,6 354-9321
350 11,3 11,8 6,0 354-9322
450 12,3 12,9 6,5 354-9323
550 13,2 13,8 6,9 354-9324
650 14,0 14,6 7,3 354-9325
750 14,6 15,3 7,6 354-9326
850 15,4 15,9 7,9 354-9327
CPG™ Implant 321
Cohesive III™, Medium Height, Moderate Projection
Volume
cc
Width
cm
Height
cm
Proj.
cm Catalog #
CPG™ Implant 331
Cohesive III™, Tall Height, Moderate Projection
Volume
cc
Width
cm
Height
cm
Proj.
cm Catalog #
MENTOR® CONTOUR PROFILE™ Breast Tissue
Expanders / CPG™ Gel Breast Implants
Sizing Guide / Two-Stage Breast Reconstruction
STAGE 1
Selection of the CPX4™Expander
CPG
CPG™ Implant 322
Cohesive III™, Medium Height, Moderate Plus Projection
Volume
cc
Width
cm
Height
cm
Proj.
cm Catalog #
CPG™ Implant 323
Cohesive III™, Medium Height, High Projection
Volume
cc
Width
cm
Height
cm
Proj.
cm Catalog #
CPG™ Implant 332
Cohesive III™, Tall Height, Moderate Plus Projection
Volume
cc
Width
cm
Height
cm
Proj.
cm Catalog #
CPG™ Implant 333
Cohesive III™, Tall Height, High Projection
Volume
cc
Width
cm
Height
cm
Proj.
cm Catalog #
- 27 -
*PLEASE NOTE: The CONTOUR PROFILE™ Tissue Expander Injection Dome is not MRI compatible. For
detailed indications, contraindications, warning and precautions associated with the use of this device,
please refer to the Product Insert Data Sheet. Individual implant dimensions may vary slightly in
products of this type. Not all units conform exactly to the dimensions noted.
Selection of CPG™ Gel Breast Implant to use as a long-term implant after
expansion is complete.
STAGE 2
CPG
- 28 -
Expanders
CPX Breast Tissue Expander
BufferZone™ Self-sealing patch and posterior Dacron® Patch.
• Protecting the chest wall whilst driving lower pole expansion to mimic
the shape of the natural breast.
Improved stronger magnet.ζ
• Easier to locate injection dome for larger patients.
Enhanced smooth, flat injection dome and shell pliability.ζ
• Helps ease insertion and removal through incision.
Better more pliant proprietary BufferZone™ Patch.ζ
• Enhanced patient comfort.
Patented SILTEX Texture.
• Prevents the pooling or sequestration of body fluids.
Implant matching.
• Matching range of definitive implants to be used after tissue expansion.
ζ Compared with the MENTOR® CPX2™ and CPX3™ Breast Tissue Expanders.
BufferZone™ Self-sealing patch and posterior Dacron® Patch.
• Protecting the chest wall whilst driving lower pole expansion to
mimic the shape of the natural breast.
Improved stronger magnet.*
• Easier to locate injection dome for larger patients.
Enhanced smooth, flat injection dome and shell pliability.*
• Helps ease insertion and removal through incision.
Better more pliant proprietary BufferZone™ Patch.*
• Enhanced patient comfort.
® Texture.
• Prevents the pooling or sequestration of
body fluids.
• Matching range of definitive implants to be
used after tissue expansion.
Patented SILTEX
Implant matching.
*Compared with the MENTOR® CPX2™ and CPX3™ Breast Tissue Expanders.
Mentor CPX4 Breast Tissue Expander
Expanders
- 29 - 27
Expanders
CONTOUR PROFILE™
Tissue Expanders
CPX™4 Breast Tissue Expander,
Low Height, Style 8100 η
Volume cc Width cm Height cm Projection cm Catalog #
250 11,4 8,1 6,1 354-8121
350 12,7 9,4 6,5 354-8122
450 14,0 10,2 7,1 354-8123
550 15,0 10,9 7,4 354-8124
650 15,7 11,2 7,9 354-8125
750 16,5 11,9 8,1 354-8126
CPX™4 Breast Tissue Expander,
Medium Height, Style 8200 η
Volume cc Width cm Height cm Projection cm Catalog #
CPX™4 Breast Tissue Expander,
Tall Height, Style 8300η
Volume cc Width cm Height cm Projection cm Catalog #
η Includes CENTERSCOPETM Magnetic Detection Device
PLEASE NOTE: Contour Profile™ Tissue Expanders are not MRI compatible
Note: Individual implant dimensions may vary slightly in products of this type.
Not all units will conform exactly to the dimensions noted above
- 30 -
Expanders
η Includes CENTERSCOPETM Magnetic Detection Device
PLEASE NOTE: Contour Profile™ Tissue Expanders are not MRI compatible
Note: Individual implant dimensions may vary slightly in products of this type.
Not all units will conform exactly to the dimensions noted above
MENTOR® CPX™4 Breast Tissue Expander
with Suture Tabs Low Height, Style 9100η
Volume cc Width cm Height cm Projection cm Catalog #
250 11,4 8,1 6,1 354-9121
350 12,7 9,4 6,5 354-9122
450 14,0 10,2 7,1 354-9123
550 15,0 10,9 7,4 354-9124
650 15,7 11,2 7,9 354-9125
750 16,5 11,9 8,1 354-9126
MENTOR® CPX™4 Breast Tissue Expander
with Suture Tabs Medium Height, Style 9200η
Volume cc Width cm Height cm Projection cm Catalog #
275 10,7 9,3 6,2 354-9221
350 11,7 10,0 6,6 354-9222
450 12,7 10,8 7,0 354-9223
550 13,5 11,7 7,4 354-9224
650 14,6 12,6 7,6 354-9225
800 15,6 13,3 8,0 354-9226
MENTOR® CPX™4 Breast Tissue Expander
with Suture Tabs Tall Height, Style 9300η
Volume cc Width cm Height cm Projection cm Catalog #
250 10,1 10,7 5,6 354-9321
350 11,3 11,8 6,0 354-9322
450 12,3 12,9 6,5 354-9323
550 13,2 13,8 6,9 354-9324
650 14,0 14,6 7,3 354-9325
750 14,6 15,3 7,6 354-9326
850 15,4 15,9 7,9 354-9327
CONTOUR PROFILE™
Tissue Expanders
- 31 -
Expanders
MENTOR® BECKER™
Expander/ Breast Implants
SILTEX™ ROUND BECKER™ 25
EXPANDER/IMPLANTS, COHESIVE I™
(25% Silicone Gel, Cohesive I™, in outer lumen,
75% Saline in inner lumen)
temporary
overexpansion
volumes
Volume
cc
Gel
Volume
cc
Max
Saline
cc
Total
Gel- Saline
cc
Total Saline
cc
Total Gel-
Saline cc
Diameter
cm
Proj.
cm Cat.#
150 40 185 225 85-150 125-190 10,7 2,4 354-1500
200 50 250 300 125-200 175-250 11,6 2,7 354-2000
250 60 315 375 165-255 225-315 12,1 3,0 354-2500
300 75 375 450 200-300 275-375 12,9 3,0 354-3000
350 90 435 525 235-350 325-440 14,1 3,0 354-3500
400 100 500 600 275-400 375-500 13,9 3,4 354-4000
500 125 625 750 350-500 475-625 14,7 3,7 354-5000
600 150 750 900 425-600 575-750 15,6 4,2 354-6000
700 175 875 1050 500-700 675-875 16,8 4,3 354-7000
800 200 1000 1200 575-800 775-1000 17,2 4,6 354-8000
Note: Individual implant dimensions may vary slightly in products of this type.
Not all units will conform exactly to the dimensions noted above
- 32 -
Expanders
SILTEX™ CONTOUR PROFILE™ BECKER™ 35
Expander/Implants, Cohesive II™
(35% Silicone Gel, Cohesive II™, in outer lumen,
65% Saline in inner lumen)
temporary
overexpansion
volumes
Volume
cc
Gel
Volume
cc
Max
Saline
cc
Total
Gel-
Saline cc
Total
Saline cc
Total Gel-
Saline cc
Width
cm
Height
cm
Proj.
cm Cat.#
MENTOR® BECKER™
Expander/ Breast Implants
Note: Individual implant dimensions may vary slightly in products of this type.
Not all units will conform exactly to the dimensions noted above
- 33 -
Expanders
- 34 -
Smooth Round Tissue Expanders
Device
Volume cc
Diameter
cm
Projection
cm Catalog #
400 11,3 5,9 350-4305M
550 13,4 5,8 350-4307M
700 14,6 6,7 350-4304M
850 15,0 7,2 350-4308M
1000 15,5 7,8 350-4306M
Smooth Elliptical Tissue Expanders
temporary
overexpansion
Device
Volume
cc
Length
cm
Width
cm
Nominal
Projection
cm Proj. cm
Max.
Volume cc Catalog #
25 6,0 4,0 2,3 4,5 75 350-5301M
breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai
Projection
cm Catalog #
Smooth Crescent Tissue Expanders
Device
Volume cc
Length
cm
Width
cm
Projection
cm Catalog #
Other Tissue Expanders
Expanders
- 36 -
Accessories
Injection Port Detector
Description
CENTERSCOPE™ Magnetic Detection Device
Injection Dome
Description
Dome Pack Set
Can be used with SPECTRUM™ Shaped Adjustable Saline Breast Implant,
Round BECKER™ Expander/Breast Implant, and Smooth Tissue Expanders
350-DOMPK
Catalog #
Catalog #
350-4402
Expanders
- 37 -
Other
Round Saline Breast Implants
Smooth Round Breast Implants,
Moderate Profile
NOMINAL FILL MAXIMUM FILL
Volume
cc
Diameter
cm
Projection
cm
Volume
cc
Diameter
cm
Projection
cm Catalog #
Sterile
Saline Sizerι
125 9,5 3,0 150 9,1 3,4 350-1610 351-125SZ
150 10,0 3,1 175 9,6 3,7 350-1615
175 10,6 3,3 200 10,0 3,9 350-1620 351-175SZ
200 11,0 3,4 225 10,4 3,9 350-1625
225 11,5 3,5 250 10,9 4,0 350-1630 351-225SZ
250 11,9 3,6 275 11,2 4,1 350-1635
275 12,3 3,7 300 11,7 4,2 350-1640 351-275SZ
300 12,6 3,7 325 12,1 4,3 350-1645
325 13,0 3,8 375 12,3 4,5 350-1650 351-325SZ
350 13,3 3,9 400 12,6 4,7 350-1655
375 13,6 4,0 425 12,8 4,8 350-1660 351-375SZ
425 14,2 4,1 475 13,5 4,9 350-1670 351-425SZ
475 14,8 4,2 525 14,2 4,9 350-1680 351-475SZ
525 15,0 4,2 575 14,5 5,1 350-1685
575 15,0 4,5 625 14,8 5,1 350-1690
625 15,2 4,6 700 14,9 5,6 350-1695
700 15,6 4,9 775 14,9 5,8 350-1697
Saline Breast Implants
- 38 -
ι Single Use Only
Note: Individual implant dimensions may vary slightly in products of this type.
Not all units will conform exactly to the dimensions noted above
Other
Saline Breast Implants
Smooth Round Breast Implants,
Moderate Plus Profile
NOMINAL FILL MAXIMUM FILL
Volume
cc
Diameter
cm
Projection
cm
Volume
cc
Diameter
cm
Projection
cm Catalog #
Sterile
Saline Sizerι
- 39 -
ι Single Use Only
Note: Individual implant dimensions may vary slightly in products of this type.
Not all units will conform exactly to the dimensions noted above
Other
Smooth Round Breast Implants,
High Profile
NOMINAL FILL MAXIMUM FILL
Volume
cc
Diameter
cm
Projection
cm
Volume
cc
Diameter
cm
Projection
cm Catalog #
Sterile
Saline Sizerι
Saline Breast Implants
- 40 -
Other
Saline Breast Implants
- 41 -
SPECTRUM™ Adjustable Saline Breast Implants
Smooth Round SPECTRUM™ Implants
NOMINAL FILL MAXIMUM FILL
Temp.
Volume cc
Min.
Volume cc
Final
Volume cc
Diameter
cm
Projection
cm
Final
Volume cc
Diameter
cm
Projection
cm Catalog #
SILTEX™ CONTOUR PROFILE™
SPECTRUM™ Implants
NOMINAL FILL MAXIMUM FILL
Temp.
Volume
cc
Min.
Volume
cc
Final
Volume
cc
Width
cm
Height
cmbreast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubaiProj.
cm
Final
Volume
cc
Width
cm
Height
cm
Proj.
cm Catalog #
275 235 275 11,5 9,5 5,1 330 11,1 9,4 6,3 354-2511
350 300 350 12,3 10,5 5,3 420 11,9 10,1 6,9 354-2512
450 380 450 13,2 11,0 6,1 540 12,7 11,0 7,5 354-2513
550 470 550 14,0 11,9 6,4 660 13,7 11,9 7,9 354-2514
650 550 650 15,0 12,7 6,6 780 14,5 12,5 8,2 354-2515
Other
Sterile Resterilizable
Gel Breast Implants Sizersε
- 42 -
Other
Sterile Resterilizable Gel Breast
Implants Sizersε
ε Resterilizable up to 10 times.
Note: Individual implant dimensions may vary slightly in products of this type.
Not all units will conform exactly to the dimensions noted above
Round Gel Breast Implant Sizers,
Moderate Plus Profileε
Volume cc Diameter
cm
Projection
cm
Catalog #
125 8,9 2,8 RSZ-1251
150 9,5 2,9 RSZ-1501
175 10,0 3,1 RSZ-1751
200 10,5 3,2 RSZ-2001
225 10,9 3,3 RSZ-2251
250 11,3 3,4 RSZ-2501
275 11,7 3,5 RSZ-2751
300 12,0 3,6 RSZ-3001
325 12,3 3,8 RSZ-3251
350 12,5 3,9 RSZ-3501
375 12,8 4,0 RSZ-3751
400 13,1 4,0 RSZ-4001
450 13,6 4,2 RSZ-4501
500 14,1 4,3 RSZ-5001
550 14,6 4,5 RSZ-5501
600 15,0 4,6 RSZ-6001
700 15,8 4,9 RSZ-7001
800 16,5 5,1 RSZ-8001
- 43 -
Other
- 44 -
Sterile Resterilizable
Gel Breast Implants Sizersε
Round Gel Breast Implant Sizers,
High Profile
Volume
cc
breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai
cm
Projection
cm
Catalog #
125 8,3 3,5 RSZ-1254
150 8,8 3,7 RSZ-1504
175 9,3 3,9 RSZ-1754
200 9,7 4,0 RSZ-2004
225 10,1 4,2 RSZ-2254
250 10,5 4,3 RSZ-2504
275 10,8 4,4 RSZ-2754
300 11,1 4,5 RSZ-3004
325 11,4 4,6 RSZ-3254
350 11,7 4,8 RSZ-3504
375 12,0 4,8 RSZ-3754
400 12,2 5,0 RSZ-4004
425 12,5 5,0 RSZ-4254
450 12,8 5,1 RSZ-4504
500 13,2 5,3 RSZ-5004
550 13,6 5,5 RSZ-5504
600 14,0 5,6 RSZ-6004
650 14,4 5,7 RSZ-6504
700 14,8 5,8 RSZ-7004
800 15,5 6,0 RSZ-8004
ε Resterilizable up to 10 times.
Note: Individual implant dimensions may vary slightly in products of this type.
Not all units will conform exactly to the dimensions noted above
Other
- 45 -
Sterile Resterilizable
Gel Breast Implants Sizersε
Round Gel Breast Implant Sizers,
Ultra High Profile
Volume
cc
Diameter
cm
Projection
cm
Catalog #
135 7,8 4,1 RSZ-5135
160 8,2 4,3 RSZ-5160
185 8,4 4,4 RSZ-5185
215 8,7 4,5 RSZ-5215
240 9,0 4,7 RSZ-5240
270 9,3 4,8 RSZ-5270
295 9,7 5,0 RSZ-5295
320 9,8 5,1 RSZ-5320
350 10,1 5,2 RSZ-5350
375 10,4 5,3 RSZ-5375
400 10,6 5,4 RSZ-5400
430 10,9 5,6 RSZ-5430
455 11,2 5,7 RSZ-5455
480 11,4 5,8 RSZ-5480
535 12,0 6,1 RSZ-5535
590 12,5 6,3 RSZ-5590
ε Resterilizable up to 10 times.
Note: Individual implant dimensions may vary slightly in products of this type.
Not all units will conform exactly to the dimensions noted above
Other
ε Resterilizable up to 10 times.
Note: Individual implant dimensions may vary slightly in products of this type. Not
all units will conform exactly to the dimensions noted above
Round Moderate Plus Profile Xtra Sterile
Resterilizable Gel Breast Implant Sizers
(for textured implants)
Volume
cc
Diameter
cm
Projection
cm
Catalog #
130 8,9 3,1 RSZMPX130
160 9,5 3,3 RSZMPX160
190 10,0 3,4 RSZMPX190
215 10,4 3,6 RSZMPX215
240 10,8 3,7 RSZMPX240
270 11,4 3,8 RSZMPX270
295 11,5 4,0 RSZMPX295
325 11,9 4,1 RSZMPX325
350 12,3 4,1 RSZMPX350
370 12,6 4,1 RSZMPX370
405 12,7 4,4 RSZMPX405
440 13,1 4,5 RSZMPX440
490 13,6 4,7 RSZMPX490
545 14,0 4,9 RSZMPX545
605 14,5 5,1 RSZMPX605
645 14,9 5,1 RSZMPX645
755 15,7 5,4 RSZMPX755
Sterile Resterilizable
Gel Breast Implants Sizersε
- 46 -
Other
Sterile Resterilizable
Gel Breast Implants Sizersε
ε Resterilizable up to 10 times.
Note: Individual implant dimensions may vary slightly in products of this type. Not
all units will conform exactly to the dimensions noted above
Round Moderate Plus Profile Xtra Sterile
Resterilizable Gel Breast Implant Sizers
(for smooth implants)
Volume
cc
Diameter
cm
Projection
cm
Catalog #
130 8,9 3,1 RSZMPX130
160 9,5 3,3 RSZMPX160
190 10,0 3,4 RSZMPX190
215 10,4 3,6 RSZMPX215
240 10,8 3,7 RSZMPX240
270 11,4 3,8 RSZMPX270
295 11,5 4,0 RSZMPX295
325 11,9 4,1 RSZMPX325
350 12,3 4,1 RSZMPX350
370 12,6 4,1 RSZMPX370
405 12,7 4,4 RSZMPX405
440 13,1 4,5 RSZMPX440
490 13,6 4,7 RSZMPX490
545 14,0 4,9 RSZMPX545
605 14,5 5,1 RSZMPX605
645 14,9 5,1 RSZMPX645
755 15,7 5,4 RSZMPX755
- 47 -
Other
- 48 -
ε Resterilizable up to 10 times.
Note: Individual implant dimensions may vary slightly in products of this type. Not
all units will conform exactly to the dimensions noted above
Round High Profile Xtra Sterile
Resterilizable Gel Breast Implant
Sizers (for textured implants)
Volume
cc
Diameter
breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai
cm
Catalog #
150 8,3 4,1 RSZTHPX150
180 8,8 4,4 RSZTHPX175
200 9,2 4,5 RSZTHPX200
235 9,5 4,9 RSZTHPX230
260 9,9 5,0 RSZ-HPX255
285 10,3 5,0 RSZ-HPX285
335 10,7 5,4 RSZTHPX325
355 11,0 5,5 RSZTHPX340
380 11,3 5,5 RSZ-HPX365
415 11,5 5,8 RSZTHPX405
450 11,9 5,9 RSZTHPX425
465 12,1 5,8 RSZTHPX455
490 12,5 5,8 RSZTHPX470
535 12,7 6,0 RSZTHPX515
595 13,1 6,3 RSZTHPX570
650 13,5 6,5 RSZTHPX620
700 14,1 6,5 RSZTHPX680
755 14,4 6,7 RSZTHPX725
790 14,8 6,7 RSZTHPX765
Sterile Resterilizable
Gel Breast Implants Sizersε
Other
- 49 -
Sterile Resterilizable
Gel Breast Implants Sizersε
ε Resterilizable up to 10 times.
Note: Individual implant dimensions may vary slightly in products of this type. Not
all units will conform exactly to the dimensions noted above
Round High Profile Xtra Sterile
Resterilizable Gel Breast Implant
Sizers (for smooth implants)
Volume
cc
Diameter
cm
Projection
cm
Catalog #
150 8,3 4,1 RSZSHPX150
180 8,8 4,4 RSZSHPX180
200 9,2 4,5 RSZSHPX200
235 9,5 4,9 RSZSHPX235
260 9,9 5,0 RSZSHPX260
285 10,3 5,0 RSZSHPX285
335 10,7 5,4 RSZSHPX335
355 11,0 5,5 RSZSHPX355
380 11,3 5,5 RSZSHPX380
415 11,5 5,8 RSZSHPX415
450 11,9 5,9 RSZSHPX450
465 12,1 5,8 RSZSHPX465
490 12,5 5,8 RSZSHPX490
535 12,7 6,0 RSZSHPX535
595 13,1 6,3 RSZSHPX595
650 13,5 6,5 RSZSHPX650
700 14,1 6,5 RSZSHPX700
755 14,4 6,7 RSZSHPX755
790 14,8 6,7 RSZSHPX790
Other
- 50 -
Sterile Resterilizable
Gel Breast Implants Sizersε
CPG™ GEL BREAST IMPLANT SIZERS
CPG™ Implant Sizers 331, Cohesive III™,
Tall Height, Moderate Projection
Volume
cc
Width
cm
Height
cm
Projection
cm
Lower Pole
Arc A-B (cm)
Catalog #
125 9,0 9,2 3,2 7,3 RSZ-0903
150 9,5 9,7 3,3 7,7 RSZ-0953
175 10,0 10,2 3,4 8,1 RSZ-1003
200 10,5 10,7 3,5 8,4 RSZ-1053
230 11,0 11,3 3,6 8,8 RSZ-1103
265 11,5 11,8 3,7 9,1 RSZ-1153
300 12,0 12,3 3,9 9,5 RSZ-1203
340 12,5 12,8 4,0 9,9 RSZ-1253
380 13,0 13,3 4,1 10,2 RSZ-1303
425 13,5 13,8 4,3 10,6 RSZ-1353
475 14,0 14,3 4,5 11,0 RSZ-1403
530 14,5 14,8 4,6 11,3 RSZ-1453
585 15,0 15,3 4,0 11,7 RSZ-1503
645 15,5 15,9 5,0 12,1 RSZ-1553
CPG™ Implant Sizers 321, Cohesive III™,
Medium Height, Moderate Projection
Volume
cc
Width
cm
Height
cm
Projection
cm
Lower Pole
Arc A-B (cm)
Catalog #
120 9,0 8,5 3,3 7,0 RSZ-0908
135 9,5 8,9 3,5 7,3 RSZ-0958
155 10,0 9,4 3,7 7,7 RSZ-1008
180 10,5 9,9 3,8 8,0 RSZ-1058
215 11,0 10,3 3,9 8,2 RSZ-1108
245 11,5 10,8 4,0 8,6 RSZ-1158
280 12,0 11,3 4,2 8,9 RSZ-1208
315 12,5 11,8 4,4 9,2 RSZ-1258
355 13,0 12,2 4,6 9,6 RSZ-1308
395 13,5 12,7 4,7 9,9 RSZ-1358
440 14,0 13,2 4,9 10,3 RSZ-1408
480 14,5 13,6 5,0 10,5 RSZ-1458
530 15,0 14,1 5,2 10,9 RSZ-1508
640 16,0 15,0 5,6 11,5 RSZ-1608
775 17,0 16,0 5,9 12,2 RSZ-1708
ε Resterilizable up to 10 times.
Note: Individual implant dimensions may vary slightly in products of this type.
Not all units will conform exactly to the dimensions noted above
Other
- 51 -
Sterile Resterilizable
Gel Breast Implants Sizersε
CPG™ Implant Sizers 311, Cohesive III™,
Low Height, Moderate Projection
Volume
cc
Width
cm
Height
cm
Projection
cm
Lower Pole
Arc A-B (cm)
Catalog #
120 9,5 8,5 3,2 6,9 RSZ-0095
140 10,0 8,9 3,4 7,2 RSZ-0100
160 10,5 9,4 3,6 7,5 RSZ-0105
180 11,0 9,8 3,7 7,9 RSZ-0110
210 11,5 10,3 3,9 8,2 RSZ-0115
235 12,0 10,7 4,1 8,5 RSZ-0120
270 12,5 11,2 4,2 8,8 RSZ-0125
300 13,0 11,6 4,4 9,2 RSZ-0130
335 13,5 12,0 4,6 9,5 RSZ-0135
375 14,0 12,5 4,7 9,8 RSZ-0140
415 14,5 12,9 4,9 10,1 RSZ-0145
460 15,0 13,4 5,1 10,5 RSZ-0150
510 15,5 13,8 5,2 10,8 RSZ-0155
560 16,0 14,3 5,4 11,1 RSZ-0160
615 16,5 14,7 5,6 11,4 RSZ-0165
ε Resterilizable up to 10 times.
Note: Individual implant dimensions may vary slightly in products of this type.
Not all units will conform exactly to the dimensions noted above
Other
- 52 -
Sterile Resterilizable
Gel Breast Implants Sizersε
CPG™ GEL BREAST IMPLANT SIZERS
CPG™ Implant Sizers 332, Cohesive III™,
Tall Height, Moderate Plus Projection
Volume
cc
Width
cm
Height
cm
Projection
cm
Lower Pole
Arc A-B (cm)
Catalog #
145 9,0 9,4 3,8 8,1 RSZ-0909
175 9,5 9,9 4,0 8,5 RSZ-0959
205 10,0 10,4 4,2 8,9 RSZ-1009
235 10,5 10,9 4,4 9,3 RSZ-1059
270 11,0 11,5 4,7 9,7 RSZ-1109
305 11,5 12,0 4,9 10,1 RSZ-1159
350 12,0 12,5 5,1 10,5 RSZ-1209
395 12,5 13,0 5,3 10,9 RSZ-1259
455 13,0 13,5 5,5 11,3 RSZ-1309
495 13,5 14,1 5,7 11,7 RSZ-1359
555 14,0 14,6 5,9 12,1 RSZ-1409
615 14,5 15,1 6,1 12,6 RSZ-1459
680 15,0 15,6 6,3 13,0 RSZ-1509
CPG™ Implant Sizers 322, Cohesive III™,
Medium Height, Moderate Projection
Volume
cc
Width
cm
Height
cm
Projection
cm
Lower Pole
Arc A-B (cm)
Catalog #
140 9,0 8,5 3,8 7,6 RSZ-0905
165 9,5 8,9 4,0 8,0 RSZ-0955
195 10,0 9,4 4,2 8,4 RSZ-1005
225 10,5 9,9 4,4 8,8 RSZ-1055
255 11,0 10,3 4,7 9,2 RSZ-1105
295 11,5 10,8 4,9 9,5 RSZ-1155
330 12,0 11,3 5,1 9,9 RSZ-1205
375 12,5 11,8 5,3 10,3 RSZ-1255
420 13,0 12,2 5,5 10,7 RSZ-1305
475 13,5 12,7 5,7 11,1 RSZ-1355
525 14,0 13,2 5,9 11,4 RSZ-1405
585 14,5 13,6 6,1 11,8 RSZ-1455
650 15,0 14,1 6,3 12,2 RSZ-1505
ε Resterilizable up to 10 times.
Note: Individual implant dimensions may vary slightly in products of this type.
Not all units will conform exactly to the dimensions noted above
Other
- 53 -
Sterile Resterilizable
Gel Breast Implants Sizersε
CPG™ Implant Sizers 312, Cohesive III™,
Low Height, Moderate Projection
Volume
cc
Width
cm
Height
cm
Projection
cm
Lower Pole
Arc A-B (cm)
Catalog #
125 9,0 8,0 3,8 7,2 RSZ-0907
145 9,5 8,4 4,0 7,5 RSZ-0957
170 10,0 8,8 4,2 7,9 RSZ-1007
195 10,5 9,3 4,4 8,3 RSZ-1057
225 11,0 9,7 4,7 8,6 RSZ-1107
255 11,5 10,2 4,9 9,0 RSZ-1157
290 12,0 10,6 5,1 9,3 RSZ-1207
330 12,5 11,1 5,3 9,7 RSZ-1257
370 13,0 11,5 5,5 10,0 RSZ-1307
415 13,5 11,9 5,7 10,4 RSZ-1357
465 14,0 12,4 5,9 10,8 RSZ-1407
515 14,5 12,8 6,1 11,1 RSZ-1457
570 15,0 13,3 6,3 11,5 RSZ-1507
690 16,0 14,2 6,8 12,2 RSZ-1607
ε Resterilizable up to 10 times.
Note: Individual implant dimensions may vary slightly in products of this type.
Not all units will conform exactly to the dimensions noted above
Other
- 54 -
CPG™ Implant Sizers 323, Cohesive III™,
Medium Height, High Projection
Volume
cc
Width
cm
Height
cm
Projection
cm
Lower Pole
Arc A-B (cm)
Catalog #
165 9,0 8,5 4,6 8,1 RSZ-0902
195 9,5 8,9 4,8 8,5 RSZ-0952
225 10,0 9,4 5,1 8,9 RSZ-1002
260 10,5 9,9 5,3 9,3 RSZ-1052
300 11,0 10,3 5,6 9,7 RSZ-1102
345 11,5 10,8 5,8 10,1 RSZ-1152
390 12,0 11,3 6,0 10,5 RSZ-1202
440 12,5 11,8 6,2 10,9 RSZ-1252
495 13,0 12,2 6,5 11,3 RSZ-1302
555 13,5 12,7 6,7 11,8 RSZ-1352
620 14,0 13,2 6,9 12,2 RSZ-1402
685 14,5 13,6 7,1 12,6 RSZ-1452
CPG™ Implant Sizers 333, Cohesive III™,
Tall Height, High Projection
Volume
cc
Width
cm
Height
cm
Projection
cm
Lower Pole
Arc A-B (cm)
Catalog #
180 9,0 9,4 4,6 8,4 RSZ-4090
215 9,5 9,9 4,8 8,8 RSZ-4095
250 10,0 10,4 5,1 9,3 RSZ-4100
290 10,5 10,9 5,3 9,7 RSZ-4105
330 11,0 11,5 5,6 10,1 RSZ-4110
380 11,5 12,0 5,8 10,5 RSZ-4115
430 12,0 12,5 6,0 11,0 RSZ-4120
485 12,5 13,0 6,2 11,4 RSZ-4125
545 13,0 13,5 6,5 11,8 RSZ-4130
610 13,5 14,1 6,7 12,2 RSZ-4135
680 14,0 14,6 6,9 12,7 RSZ-4140
755 14,5 15,1 7,1 13,1 RSZ-4145
ε Resterilizable up to 10 times.
Note: Individual implant dimensions may vary slightly in products of this type.
Not all units will conform exactly to the dimensions noted above
Sterile Resterilizable
Gel Breast Implants Sizersε
CPG™ GEL BREAST IMPLANT SIZERS
Other
- 55 -
CPG™ Implant Sizers 313, Cohesive III™,
Low Height, High Projection
Volume
cc
Width
cm
Height
cm
Projection
cm
Lower Pole
Arc A-B (cm)
Catalog #
130 9,0 8,1 4,4 7,6 RSZ-0906
155 9,5 8,6 4,5 7,8 RSZ-0956
180 10,0 9,0 4,6 8,3 RSZ-1006
210 10,5 9,5 4,8 8,7 RSZ-1056
240 11,0 9,9 4,9 9,1 RSZ-1106
270 11,5 10,3 5,0 9,5 RSZ-1156
310 12,0 10,8 5,2 9,9 RSZ-1206
350 12,5 11,2 5,4 10,2 RSZ-1256
395 13,0 11,7 5,6 10,6 RSZ-1306
440 13,5 12,2 5,8 11,0 RSZ-1356
490 14,0 12,6 6,1 11,4 RSZ-1406
545 14,5 13,1 6,3 11,7 RSZ-1456
605 15,0 13,5 6,6 12,1 RSZ-1506
ε Resterilizable up to 10 times.
Note: Individual implant dimensions may vary slightly in products of this type.
Not all units will conform exactly to the dimensions noted above
Sterile Resterilizable
Gel Breast Implants Sizersε
Other
Sterile Saline Breast
Implant Sizers
Round Saline Breast Implant Sizers,
Moderate Profile
NOMINAL FILL MAXIMUM FILL
Volume
cc
Diameter
cm
Projection
cm
Volume
cc
Diameter
cm
Projection
cm Catalog #
125 9,5 3,0 150 9,1 3,4 351-125SZ
175 10,6 3,3 200 10,0 3,9 351-175SZ
225 11,5 3,5 250 10,9 4,0 351-225SZ
275 12,3 3,7 300 11,7 4,2 351-275SZ
325 13,0 3,8 375 12,3 4,5 351-325SZ
375 13,6 4,0 425 12,8 4,8 351-375SZ
425 14,2 4,1 475 13,5 4,9 351-425SZ
475 14,8 4,2 525 14,2 4,9 351-475SZ
Round Saline Breast Implant Sizers,
Moderate Plus Profile
NOMINAL FILL MAXIMUM FILL
Volume
cc
Diameter
cm
Projection
cmbreast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubaiVolume
cc
Diameter
cm
Projection
cm Catalog #
175 9,5 3,5 210 9,3 4,2 351-2175SZ
200 10,0 3,7 240 9,7 4,4 351-2200SZ
225 10,4 3,8 270 10,1 4,6 351-2225SZ
250 10,8 4,0 300 10,5 4,7 351-2250SZ
275 11,0 4,1 330 10,8 4,9 351-2275SZ
300 11,5 4,3 360 11,2 5,0 351-2300SZ
325 11,9 4,4 390 11,5 5,2 351-2325SZ
350 12,1 4,5 420 11,7 5,3 351-2350SZ
375 12,3 4,6 450 12,0 5,4 351-2375SZ
400 12,6 4,7 480 12,3 5,5 351-2400SZ
425 12,9 4,8 510 12,5 5,6 351-2425SZ
450 13,0 4,9 540 12,8 5,7 351-2450SZ
475 13,3 5,0 570 13,0 5,8 351-2475SZ
500 13,6 5,1 600 13,2 5,9 351-2500SZ
550 14,0 5,3 660 13,7 6,1 351-2550SZ
600 14,5 5,5 720 14,1 6,3 351-2600SZ
650 14,8 5,6 780 14,4 6,5 351-2650SZ
700 15,2 5,8 840 14,8 6,6 351-2700SZ
750 15,6 5,9 900 15,1 6,8 351-2750SZ
800 16,1 6,0 960 15,5 7,0 351-2800SZ
Other
- 57 -
Sterile Saline Breast
Implant Sizers
CONTOUR PROFILE™ Saline
Breast Implant Sizers, High Profile
Volume
cc
Width
cm Height cm Projection cm Catalog #
275 + 25 11,5 9,5 5,1 351-0711SZ
350 + 50 12,3 10,5 5,3 351-0712SZ
450 + 50 13,2 11,0 6,1 351-0713SZ
550 + 50 14,0 11,9 6,4 351-0714SZ
650 + 75 15,0 12,7 6,6 351-0715SZ
Round Saline Breast Implant Sizers,
High Profile
NOMINAL FILL MAXIMUM FILL
Volume
cc
Diameter
cm
Projection
cm
Volume
cc
Diameter
cm
Projection
cm Catalog #
190 9,3 4,1 225 9,1 5,1 351-3190SZ
230 10,0 4,3 275 9,8 5,5 351-3230SZ
270 10,4 4,6 325 10,2 5,8 351-3270SZ
290 10,8 4,7 350 10,5 5,9 351-3290SZ
310 11,0 4,8 375 10,7 6,0 351-3310SZ
330 11,3 4,8 400 11,0 6,2 351-3330SZ
380 11,7 5,2 450 11,4 6,4 351-3380SZ
420 12,0 5,4 500 11,7 6,7 351-3420SZ
500 12,8 5,6 600 12,4 7,1 351-3500SZ
630 13,8 5,9 750 13,4 7,4 351-3630SZ
Note: Individual implant dimensions may vary slightly in products of this type.
Not all units will conform exactly to the dimensions noted above
- 58 -
References
1. Based on warranty comparisons of the following breast implants:
Allergan Natrelle: http://www.natrelle.co.uk/breast-enhancement/Pages/
warranty.aspx, EuroSilicone & Nagor: http://nagor.com/pdf/Warranty_
PDF_Nagor.pdf, Arion: http:// www.laboratoires-arion.com images/ arion/
ARION_GUARANTEE_PROGRAM_ANG.pdf, Polytech: http://www.polytechhealth.
info/ images/pdf/IoE_ Information_engl_2015- 01.pdf, Motiva: https://
motivaimplants.com/productwarranty/Sebbin: Garantie des IMPLANTS
MAMMAIRES and La garantie premium, Accessed March 20 2017.
2. Mentor Worldwide, LLC. MemoryShape® Post-Approval Cohort Study
(formerly Contour Profile Gel Core Study) Final Clinical Study Report. 02 June
2015 Mentor Worldwide LLC. Data on File. MemoryGel® Core Gel Clinical Study
Final Report, April 2013. Maxwell, G. Patrick; Van Natta, Bruce W.; Bengtson,
Bradley P.; and Murphy, Diane K., «Ten-Year Results From the Natrelle 410
Anatomical Form-Stable Silicone Breast Implant Core Study» (2015). Public
Health Resources. Health Canada: Summary Basis of Decision (SBD) for
Natrelle™ Highly Cohesive Silicone-Filled Breast Implants. Application No.
88573. License No.72262. Date Issued: 2014/01/17. Health Canada: Summary
Basis of Decision (SBD) for Natrelle™ Silicone-Filled Breast Implants-Smooth
Shell With Barrier and Narelle(TM) Silicone Filled Breast Implants - Textured
Shell with Barrier Layer. Application No. 61865 and 60524 License No License
No 72264 and 72263. Date Issued: 2012/09/25.
3. Danino, A. M., Basmacioglu, P., Saito, S., Rocher, F., Blanchet-Bardon, C., Revol, M.,
& Servant, J. M. (2001). Comparison of the capsular response to the Biocell RTV
and Mentor 1600 Siltex breast implant surface texturing: a scanning electron
microscopic study. Plastic and reconstructive surgery, 108(7), 2047-2052.
- 59 -
4. Mentor Worldwide, LLC. MemoryShape® Post-Approval Cohort Study
(formerly Contour Profile Gel Core Study) Final Clinical Study Report. 02 June
2015
5. Health Canada: Summary Basis of Decision (SBD) for Natrelle™ Highly
Cohesive Silicone-Filled Breast Implants. Application No. 88573. License
No.72262. Date Issued: 2014/01/17.
6. Maxwell, G. Patrick, et al. «Ten-year results from the Natrelle 410 anatomical
form-stable silicone breast implant core study.» Aesthetic Surgery Journal 35.2
(2015): 145-155.
7. Hoffman_CP529_530Interim_Report_for_CP529_DOF_PR_20131007 (PDF pg. 2)
8. Mentor Worldwide LLC, Data on File, HS820.050331.02F Validation Case
Study Report: Market Acceptance of the Contour Profile Gel Product Family -
TX.820.081125.01
9. As compared to the CONTOUR PROFILE® Tissue Expanders at 5 mm. Data on
file at Mentor Worldwide LLC.
10. Mentor Consumer Preference Market Research Report – July 2017.
11. Product Dimensions for MemoryGel™ and MemoryGel™ Xtra Breast
Implants Mentor R&D Benchtop Testing (Pinch Test) - July 2017.
Important Safety Information
MENTOR® Breast Implants are indicated for breast augmentation, in women who
are at least 18 years old, or for breast reconstruction. Breast implant surgery
should not be performed in women with active infection anywhere in their
body, with existing cancer or pre-cancer of their breast(s) who have not received
adequate treatment for those conditions or who are pregnant or nursing.
There are risks associated with breast implant surgery. Breast implants are not
lifetime devices and breast implantation is not necessarily a one-time surgery.
The most common complications with MENTOR® MemoryGel™ Breast Implants
include re-operation, implant removal, capsular contracture, asymmetry, and
breast pain. A lower risk of complication is implant rupture, which is most
often silent. The health consequences of a ruptured silicone gel-filled breast
implant have not been fully established. Screenings such as mammography,
MRI, or ultrasound are recommended after initial implant surgery to assist in
detecting implant rupture.
The most common complications with MENTOR® Saline-Filled Implants include
re-operation, implant removal, capsular contracture, wrinkling, deflation,
asymmetry, and breast pain.
MENTOR® CPX™4 Breast Tissue Expanders can be utilized for breast
reconstruction after mastectomy, correction of an underdeveloped breast, scar
revision and tissue defect procedures.
These expanders are intended for temporary subcutaneous or submuscular
implantation.*
CONTOUR PROFILE™ Tissue Expanders are devices that contain magnetic
injection domes and are NOT MRI compatible. Do not use the CONTOUR
PROFILE™ Tissue Expander in patients where an MRI may be needed. DO NOT
use the CONTOUR PROFILE™ Tissue Expander in patients that have a previously
- 60 -
implanted device that could be affected by a magnetic field. The device could
be moved by the MRI causing pain or displacement, potentially resulting in a
revision surgery. The incidence of extrusion of the expander has been shown
to increase when the expander has been placed in injured areas: scarred,
heavily irradiated or burned tissue, crushed bone areas or where severe surgical
reduction of the area has previously been performed.
Your patient needs to be informed and understand the risks and benefits of
breast implants, and provided with an opportunity to consult with you prior to
deciding on surgery.
For detailed indications, contraindications, warning and precautions associated
with the use of all MENTOR® Implantable Devices, please refer to the Product
Insert Data Sheet provided with each product, or review the Important Safety
Information provided at www.mentorwwllc.eu.
- 61 -
Mentor Worldwide LLC
33 Technology Drive Irvine, CA 92618, USA
Tel: +1 8006368678
www.mentorwwlc.eu
FAQ: Breast Augmentation
What is a breast augmentation?
A breast augmentation involves putting breast implants in your chest to enhance your natural breast tissue and make your breasts fuller and larger.
What type of implants are there?
Dr. Coon uses silicone implants made by Mentor. There are different profiles available. You will be able to see the implants during your consultation and you and the surgeon will determine what profile is best for your body.
Can I try on the implants to know what size I want?
During your consultation, you will be able to “try on” some implant samples to inform the surgical team with approximate sizes. Please bring a cami tank top to aid in this process.
Where are the implants placed?
There are two locations that an implant can be placed, either above or below the muscle. You and your surgeon will talk about what the best surgical option is for your body.
What determines the size of the implants?
This is a conversation you and your surgeon will have to determine what size is best for your body frame. It is important to keep in mind that skin stretching may limit the size of the implant.
Where is the incision?
There will be a small surgical incision made underneath the breast where we insert the implant. This incision is typically hidden under the natural fold of the breast and is hardly noticeable.
How long is the surgery?
On average, the surgery takes 2-4 hours.
Will I be in a lot of pain after surgery?
You may experience some discomfort for a few days after surgery, but generally 4-5 days after surgery you will be able to return to your normal activities.
Will I have surgical drains?
No, this procedure does not require you to go home with any drains.
What dressings will I go home with after surgery?
You will go home with steri strips over the incision line and a large clear band aid, called tegaderm. This dressing will be removed 2 week after surgery during your post-operative visit with clinical staff.
FAQ: Breast Augmentation
Can I shower after surgery?
You may begin showering the day after surgery. Do not scrub at your incision line or remove the dressing placed in the operating room.
What bra can I wear after surgery?
After surgery you will be given a special bra that you must continue to wear for 3 weeks. This bra will be provided by the hospital and placed on you in the operating room. After 3 weeks, you may begin wearing a sports bra or a soft cloth bra – you should NOT wear an underwire bra for at least 6 weeks after surgery.
What limitations do I have after surgery?
For 4 weeks after surgery, you should not lift your hands over your head. You should also not push, pull, or lift anything greater than 5 pounds during these 4 weeks.
Am I required to do implant exercises after surgery?
Yes, you should begin performing implant exercises twice a day starting 5 days after surgery. You should continue these exercises for 3 months after your surgery date. Each breast should be gently pushed up, to the left, and to the right and held for a few seconds. These exercise helps to prevent capsular contractions, which is a pocket around the breast that keep the implant from freely moving. There are more details available in your post-op instructions, which you will receive prior to your surgery.
When can I begin scar therapy?
You can begin scar therapy approximately 8 weeks after surgery. You can start simply with scar massage, which involves using shea or cocoa butter and gently massaging the scar. If you feel like you need additional scar care, you can use creams, such as Mederma, or silicone-based gels.
Remember, it can take up to 18 months for a scar to fully mature and fade.
Is there any long term follow-up need after surgery?
It is recommended by the FDA that patients with silicone implants should receive a MRI 3 years post-operatively and every 2 years after. Despite recent news, there is no apparent association between silicone gel-filled breast implants and connective tissue disease or breast cancer.
G
C H A P T E R 54
The dual plane approach to
breast augmentation
Steven Teitelbaum
History
The breast implant pocket choice has a profound effect on
the appearance of the augmented breast. Along with the selection
of the device itself, it is the most important preoperative
decision. Critical manifestations of this choice may not be
apparent for many years, as some effects of the implant on
the soft tissue occur gradually yet inexorably.
The most commonly described pocket locations are: (1)
total submuscular (subserratus and subpectoral); (2) partial
retropectoral (behind the pectoralis with its origins from the
ribs left intact); (3) subfascial (between the pectoralis muscle
fascia and the pectoralis muscle); (4) submammary or subglandular
(between the breast and the pectoralis fascia).
Total submuscular is more frequently a reconstructive technique,
less commonly done for augmentation owing to a
more painful and bloody dissection, a tendency for the device
to rise superiorly, and diffi culty in predictably creating a deep
and well-formed inframammary fold. Subfascial has not been
widely adopted due to an absence of satisfactorily controlled
or long-term data. With scarcely 0.5 – 1 mm more coverage
than a classic submammary dissection, this procedure is only
a minor variation of the submammary pocket and does not
qualify as a distinct pocket type.
Partial retropectoral and submammary are the most
popular methods. Proponents of each are quick to point
out the distinct advantages of their technique and the disadvantages
of the other. These comments are frequently
appropriate.
But these comments are not equally applicable to all situations.
There are indeed breast types for which the benefi ts
and drawbacks of one pocket makes it the better choice. Even
so, some shortcomings of that preferred pocket frequently
remain at issue.
The dual plane as fi rst published by John Tebbetts in 2001
is the ideal compromise, in that it allows the implant to be
simultaneously retropectoral where the device most needs
coverage, and retromammary where it most needs to be in
direct apposition to the breast. This allows near-total achievement
of the purported benefi ts of both at the same time,
while minimizing the trade-offs associated with selecting just
one of the two pockets. It is therefore less of a compromise
per se, than a way of “ having your cake and eating it, too ” ,
essentially doing both pockets at once, using each pocket
where it exacts its greatest benefi t.
While submammary and partial retropectoral are “ pure ”
extremes, the dual plane is a continuous spectrum of options,
occupying the “ gray-zone ” in between. The operation starts
with the creation of a partial retropectoral pocket. The origins
are carefully divided along the inframammary fold, which
allows the cut edge of the muscle to glide a bit superiorly, so
that there is both a small submammary and a large subpectoral
area of the pocket, and hence the term dual plane. By
disrupting attachments of the muscle to the overlying gland,
the muscle can be gradually and incrementally raised, thereby
reducing the proportion of subpectoral pocket and increasing
the proportion of submammary pocket. The purported advantages
of the partial retropectoral pocket are predominantly
coverage along the sternum and over the superior border of
the implant; the dual plane preserves these. The purported
advantages of the submammary pocket are to direct implant
pressure upon the lower pole; the dual plane preserves these
as well ( Fig. 54.1 ).
Criteria for the ideal pocket
Our ability to determine the ideal pocket for a given situation
rests upon the criteria that we choose to use to make that determination.
Rather than vague, subjective decisions that allow
certain issues to be overemphasized and others neglected, it is
important to attempt to quantify all of the pertinent issues and
measure each of the methods against them.
Over the last several decades, published reoperation rates
in PMA studies have not changed despite the use of different
implants, remaining consistently at about 20% at three years.
In a study of one device, a single surgeon achieved a 0%
675
Section 11: The breast
Go to www.expertconsult.com
to see updates to this chapter
0060_ch54_9780702031687.indd 675 4/8/2009 3:33:26 PM
G
Se breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai ction 11: The breast
Aesthetic Plastic Surgery
676
deforming and even uncorrectable. It is therefore not enough
just to tally complications, but also to consider their
severity.
Dual plane data objectively show that this procedure succeeds
in maintaining the advantages of both pockets while
mitigating the trade-offs associated with selecting a single
pocket.
Preservation of future options in the event of an unsatisfactory
outcome is important: if Plan A was still a viable option
after Plan B, but Plan B would not be after Plan A, then that
would suggest an advantage for starting with Plan B.
Finally, outcomes need to be assessed at long intervals after
surgery. Irrevocable, permanent, progressive, and at times
totally uncorrectable changes occur to a breast years after an
augmentation. Adequacy of tissue coverage needs to be judged
at the longest possible intervals, decades if possible. Such
long-term data is meager, but owing to the importance of
such lifelong changes on the breast, at this point anecdote
and extrapolation of shorter-term results should be considered
( Fig. 54.3 ; Table 54.1 ).
Pain and recovery
In general, there is less pain with the submammary approach,
as the submuscular approach subjects the sensitive rib cage
to possible trauma and the overlying muscle to stretching. But
the largest data ever assembled on postoperative pain showed
that 24-hour recovery without the use of any narcotics or
pain pumps could be routinely achieved with a dual plane
approach. Bloodless surgery and avoidance of creating any rib
trauma circumvented the typical pain experienced from the
rib cage in submuscular patients. Precise, gentle elevation,
bloodless elevation of a pectoralis muscle paralyzed by the
anesthesiologist results in a minimum of trauma to the
muscle.
This author has routinely been using these techniques for
many years, and only uses ibuprofen for postoperative pain
for routine augmentation mammaplasty in all planes, including
the dual plane. Dual plane patients routinely go out to
dinner, shower, and wash and brush their own hair the night
of surgery. They describe the feeling as “ tight ” , a “ pressure ” ,
“ soreness ” , or “ like working out hard ” .
Fig. 54.1 The three types of dual plane breast augmentation. A , Dual Plane Type I. B , Dual Plane Type II. C Dual Plane type III.
A B Complete division along IMF C
No division
No division
No division
Fig. 54.2 Retromuscular pockets are often criticized for causing high-riding
implants. In this case, the dissection was a blunt/blind transaxillary
augmentation. The muscle was divided along the IMF on the left, but not the
right. This is not a shortcoming of the procedure itself, but from its execution
in this particular instance.
3-year reoperation rate in contrast to an average of 13.9% for
all the doctors in the study. Taken together, these two fi ndings
demonstrate that the outcome in breast augmentation is
determined far less by the type of the device than by other
factors ( Fig. 54.2 ).
In the absence of data, surgeons must turn to the anecdotal.
But when data is available, it trumps anecdote. Of all
endpoints, the most decisive measurement of outcome is the
reoperation rate, as it is an incontrovertible endpoint. “ Satisfi
ed ” or “ happy ” patients are imprecise and unquantifi able
endpoints, and since we have all seen unhappy patients with
beautiful results and thrilled patients despite notable problems,
they do not qualify as adequate endpoints with which
to entirely judge the quality of an operation.
The absolute incidence of reoperation tells only part of the
story: the severity of a problem must also be considered.
Some may be minor or annoying, while others may be
0060_ch54_9780702031687.indd 676 4/8/2009 3:33:26 PM
G
Chapter 54 The dual plane approach to breast augmentation
677
Fig. 54.3 A & C , Preoperative. B & D , Postoperative. Anecdotes are anecdotal, but sometimes that is the best that we have. If anyone doubts the importance of
muscle coverage, they should be shown a series of patients with tissue so thin, with a saline implant looking like this, 11 years after surgery, free from capsular
contracture, visible edges or rippling. Cases like this abound, but there are few examples of submammary or subfascial patients at this interval that look this
good.
A B
C D
When these same techniques are applied to the submammary
approach, patients typically feel slightly less stiff and
sore than do dual plane patients, but both groups still consistently
achieve a “ 24-hour ” recovery. Any difference is
subtle, noted only for a day or two, and is of no real consequence,
particularly relative to advantages of achieving more
muscle coverage.
Coverage and stretch
Soft tissue coverage is the single-most important issue affecting
the short and long-term result after a breast augmentation.
With adequate coverage, the implant edges are less
visible, and the breast looks more natural and less augmented.
Any folds or irregularities with the implant shell are more
concealed. With more tissue over it, the device is less palpable.
With less tissue coverage, the edges of the implant are
more visible, the breast looks more augmented, and it is
easier to feel the implant ( Fig. 54.4 ).
Over the long term, these changes become more profound.
Implants put pressure on the breast, and the parenchyma
gradually compresses and atrophies. The presence of the
implant stretches and thins skin. This occurs with implants
in all positions. No study will ever randomize patients of
similar tissue types and implant sizes and follow them over
enough time for a scientifi c conclusion to be made. But a large
amount of clinical observation and logic (see Fig. 54.3 and
Fig. 54.5 ) offers us guidance.
Examples of submammary patients with severe parenchymal
atrophy abound, while retropectoral patients with similar
characteristics are rarely seen. And when they are, though the
implants may have ostensibly been placed “ behind the
muscle ” , secondary surgery frequently reveals that the muscle
has been avulsed off both the inframammary fold and
sternum, thereby sacrifi cing the critical coverage of which we
are speaking ( Fig. 54.6 ).
These problems are sometimes noticeable within a year or
two, but can often take years more to develop. We must be
0060_ch54_9780702031687.indd 677 4/8/2009 3:33:28 PM
G
Section 11: The breast
Aesthetic Plastic Surgery
678
Table 54.1 Pocket comparisons
breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai Issue Advantage
PRP
Advantage
subglandular
Dual plane remedies
Less pain X Best data to date
Better coverage X Large advantage vs. SM; difference relative to PRP
dependent upon release and up to determination of
surgeon
Access to lower pole parenchyma X Yes
Expands constricted breasts X Yes
Fills ptotic breasts X Yes
Avoids muscle animation X Rarely clinically signifi cant
Reduces tendency to “ ride high ” X Yes
Reduces tendency to “ lateralize ” X Yes
Faster recovery X Best data to date
Less capsular contracture X Best data to date
Better for mammograms X Appears to be
Reduce parenchymal atrophy X Best data to date
Reduces stretch deformities Best data to date
Narrower cleavage X No – but subglandular can only do so at the expense of
coverage
Fig. 54.4 Tissue coverage is always a priority, particularly superiorly and
medially. The implant she holds in her hand mimics what is occurring within
her breast. With muscle coverage in the upper pole, such a deformity will
rarely if ever occur.
Fig. 54.5 This is not a capsular contracture. This is a submammary implant.
The breast is soft. The patient chose this at the surgeon ’ s behest in order to
avoid animation deformity. But even in repose, the signifi cant deformity is
present; there is no substitute for soft tissue coverage.
aware of these problems and remind ourselves that we need
to create a result that will look good not just for years, but
for decades. As someone who sees many secondary problems,
I can state categorically that subglandular patients present
more frequently, with more severe problems, and with more
unsolvable problems than do subpectoral or dual plane
patients.
Such tissue thinning with submammary patients also is a
set up for a problem which is diffi cult to correct, as to do so
often requires a switch to the partial retropectoral or dual
plane position. But once there is a subglandular pocket, the
coverage in the retropectoral pocket is forever impaired.
Though one can use sutures to tack the muscle back up to the
gland, its caudal cut edge can never be retained as caudally
as it might have been were this not to have happened, thereby
forever impairing inferior coverage. Marionette pullout
sutures have been described to hold down the muscle in this
situation, but this also cannot achieve the same degree of
0060_ch54_9780702031687.indd 678 4/8/2009 3:33:31 PM
G
Chapter 54 The dual plane approach to breast augmentation
679
Fig. 54.6 This patient just had removal of subpectoral implants. The
dotted line indicates the caudal border of the pectoralis. Though she had
“ retromuscular ” pockets, the implant itself had negligible if any coverage as
the muscle was so high it could cover only a bit of the implant, and the
pressure of it probably pushed the implant away. Though her muscle was still
attached to the sternum, the muscle had been inadvertently detached from
the overlying parenchyma, thereby allowing it to window shade up far higher
than would be ideal even for a DP III.
Fig. 54.7 This patient had a submammary capsulectomy and then had a
submuscular pocket dissected. It illustrates the basic principle of the DP
approach. With no attachment of the muscle to the overlying parenchyma,
this muscle window shades strongly superiorly. The DP approach recognizes
the importance of maintaining those attachments when it is important to
keep the muscle inferiorly to maintain coverage, and emphasizes the
importance of a gradual and incremental release of them to allow controlled
vertical elevation of the muscle and exposure of the parenchyma in the lower
breast when the situation demands.
Fig. 54.8 The most common argument for submammary placement is to deal with the postpartum involution and ptosis patient who does not want
mastopexy scars. But this group has the thinnest tissue and is the most prone to stretch and thinning. A , A patient merely two years following such a
procedure; note the extreme parenchymal atrophy and skin thinning. B , Note the improvement still noted two years after conversion to a dual plane.
A B
coverage as if the attachments between the muscle and the
overlying gland were never disrupted ( Fig. 54.7 ).
In conjunction with the thinning, there is often progressive
stretch of the skin envelope, sometimes necessitating mastopexy.
Even if this mastopexy would have been inevitable in
the future with a partial retropectoral or dual plane pocket,
such patients frequently have soft tissue thinning or capsular
contractures in addition to the stretched skin. This necessitates
a pocket change and possible capsulectomy in addition
to the mastopexy, which can be a riskier procedure than if the
implant had started out dual plane or partial retropectoral.
This combination of secondary revision occurs so frequently
that efforts must be made at the time of the original surgery
so that this doesn ’ t happen ( Fig. 54.8 ; also see Fig. 54.5 ).
If tissue coverage is adequate, it almost doesn ’ t matter what
is going on with the implant; a capsular contracture may be
less noticeable; suboptimal implant shape may be less problematic;
implant folds might be harder to discern. These are
powerful reasons to select the partial retropectoral pocket
over the submammary pocket.
But what should one do if there is glandular ptosis or a
constricted lower pole and the tissue is thin? Partial retropectoral
is preferred for the tissue coverage issue, but submammary
may be necessary to allow better expansion of the lower
pole. The dual plane solves this dilemma by allowing the
upper and inner portion of the implant to be covered by
muscle, while the inferior portion, the part that needs to push
directly on the gland to expand and fi ll it, can be allowed to
be in direct apposition.
Achieving “ adequate ” coverage is an insuffi cient goal.
“ Maximum ” coverage must be the goal. There is almost no
long-term problem that is not solvable when substantial soft
tissue is available, and there are few problems completely
correctable when soft tissue is not available.
There is some sacrifi ce in coverage with the dual
plane relative to partial retropectoral, and if tissue coverage
in the lower pole is such that the benefi ts of changing to the
dual plane do not outweigh its advantages, then it is suggested
to patients to have a partial retropectoral pocket.
In any case, the reduction in coverage with the dual
0060_ch54_9780702031687.indd 679 4/8/2009 3:33:33 PM
G
Section 11: The breast
Aesthetic Plastic Surgery
680
plane relative to partial retropectoral is reasoned and
controlled.
Access to parenchyma
The most profound advantage of submammary over partial
retropectoral is attributable to the direct pressure the implant
can make against the gland. This can make it look less empty,
and the pressure can better expand a tight lower pole. If
behind the muscle, the muscle essentially protects the preexisting
confi guration of the lower pole, inhibiting the
implant ’ s ability to push it and fi ll it out. And if weak fi brous
connections between the pectoralis muscle and breast gland
allow the gland to slipe relative to the muscle, placing the
implant against the breast tissue can help reduce the extent
of inferior tissue migration. Otherwise, the subpectoral placement
still allows the gland to slide inferiorly relative to the
muscle ( Figs 54.9 and 54.10 ).
Depending upon the degree of release with the dual plane,
these advantages of the submammary approach can be almost
completely if not completely realized with the dual plane
approach. The coverage that is preserved superiorly and medially
typically allows for muscle coverage where it is most
needed: superiorly and along the medial sternal border.
Capsular contracture
Capsular contracture still remains the leading cause of reoperation
in PMA studies, yet publications using antibiotic irrigation
and the dual plane pocket have resulted in some of
the lowest reported capsular contracture rates to date. Whether
it is specifi cally due to the dual plane per se or other factors,
such as the irrigation, is not entirely clear. But it is suffi cient
to say that the lowest reported capsular contracture rates are
with the dual plane position, and no paper suggests an advantage
to partial retropectoral over dual plane. Dual plane is the
ideal choice.
Mammography
Given the cancer prone nature of the breast, optimizing the
ability to detect cancer early must remain a priority. Numer-
Fig. 54.9 The long term stability of the outcome in this post partum atrophy/ptosis patient with implants in the dual plane position demonstrates the value of
proper implant sizing and tissue coverage.
pre 5 months 1 yr
2 yrs 3 yrs 5 yrs
0060_ch54_9780702031687.indd 680 4/8/2009 3:33:37 PM
G
Chapter 54 The dual plane approach to breast augmentation
681
ous authors have suggested an advantage to retropectoral over
submammary placement for this regard, but it is unclear
whether the advantage is directly due to the anatomic location
relative the muscle itself, or due to a lower capsular
contracture rate below the muscle. Suffi ce to say, mammogram
is impaired when the breast tissue cannot be pulled out
and away from the implant and placed between the mammogram
plates, such as when the implant is hard, there is a
large implant relative to the breast tissue, or any other reason
that restricts the pull of the tissue forward. While no studies
have specifi cally compared sensitivity of mammogram
between these pockets over a long period of time, the low
incidence of capsular contractures and the extensive muscular
coverage over a dual plane implant suggests that this would
not be a problem. In any case, the role of MRI in screening
for breast cancer is increasing, even for women without breast
implants. And since implants do not affect its sensitivity, this
entire issue may soon be moot.
Muscle animation
The lack of signifi cant implant motion or distortion with
contraction of the pectoralis is a signifi cant advantage of the
submammary position relative to the partial retropectoral
pocket. But it is not enough to look at the problematic subpectoral
patients with animation problems: one must also
be aware of the submammary patients with signifi cant
implant visibility even in repose. The deformity of a thin
patient with subglandular implants at rest is typically more
profound than a partial retropectoral patient during maximal
contracture.
With the dual plane approach, the release of the pectoralis
along the inframammary fold (IMF) reduces if not totally
eliminates the forces that might distract the implant superiorly.
While the medial origins along the sternum may compress
and slightly lateralize the implant on strong contraction,
they rarely cause a signifi cant deformity ( Fig. 54.11 ).
Fig. 54.10 The constricted lower pole breast is frequently touted as being a reason for submammary, as it allows scoring of the lower pole. In this case, shown
here at 5 years post-surgery, a DP II was done, allowing the muscle to rise to the lower border of the areola. This exposed parenchyma for the entire lower pole
of the breast, allowing it to be shaped just as much as it would have been were this to have been a submammary placement, but with maintenance of muscle
coverage superiorly and medially, which helps to obscure the borders of the implant.
0060_ch54_9780702031687.indd 681 4/8/2009 3:33:39 PM
G
Section 11: The breast
Aesthetic Plastic Surgery
682
Certainly, there is some motion, but in the Tebbetts series,
there was no revision requested for this reason. In my experience,
there has been occasional complaint and discussion of
revision, but I have not switched my own patient to a submammary
pocket for this reason ( Fig. 54.12 ).
Usually, the patients with any such problems are very
thin, and were therefore the least well suited for a submammary
pocket. The key in minimizing animation with the dual
plane pocket is to uniformly and accurately take the muscle
down along the inframammary fold, stopping evenly on both
sides at the point at which the IMF meets the sternum, and
never releasing along the sternum. It appears that when the
IMF is horizontal and meets the sternum at a discrete point,
these issues are less problematic than when the IMF curves
sharply superiorly as it moves towards the sternum, oftentimes
not actually meeting the sternum until being at or even
above the level of the nipple. These patients are also often
thin, and they represent a particular challenge, in that there
in fact may be no way to avoid some deformity with either
approach.
Fig. 54.11 A critical step of all dual planes – I, II, and III – is to completely
divide the pectoralis major along the inframmary fold, stopping at the
sternum, without division along the sternum. Failure to divide the origins
along the IMF result in either a high-riding implant, superior malposition with
animation, or a blunted IMF. However, if tissue coverage is thin ( < 5 mm), they
probably should not be divided, as maintaining coverage is the fi rst priority.
Division along the sternum can result in symmastia, excessive edge visibility
and uncorrectable deformities.
Complete division along IMF
No division
Fig. 54.12 DP and all retromuscular pockets are criticized for animation deformities. But the patient needs to be considered in repose as well. Here the same
patient on the top is seen submammary, relaxed in two different poses. Though there is no animation deformity, the implants are unattractive. In the lower left,
she is shown relaxed in the DP position, looking much prettier and more natural. In the lower right, she does demonstrate distortion with contracture, but no
doubt even if this is the maximal distortion she can manage, it is still less deformed than she looks in either of the preoperative views in repose.
0060_ch54_9780702031687.indd 682 4/8/2009 3:33:44 PM
G
Chapter 54 The dual plane approach to breast augmentation
683
No matter which pocket is selected, the patient must be
fully informed preoperatively of the trade-offs, and participate
in the pocket selection. That way, if she has an animation
deformity or implant deformity later, she can be reminded
that she preferred accepting that problem to the risks of the
other pocket. If a patient is not made aware of these choices
preoperatively, then dissatisfaction and request for revision
remain avoidable risks for revision.
Narrower cleavage
Both partial retropectoral and dual plane procedures accept
the inner border of the pectoralis major muscle as an absolute
limit to the medial placement of the implants. Once submammary,
the implant can certainly be more medial.
However, this comes at a price: the patients who most request
or “ need ” such medialization invariably have the least soft
tissue cover, and moving the implant medial to where the
internal border of the pectoralis origin on the sternum results
in risking symmastia and excessively visible implant edges. It
is foolhardy to attempt to create cleavage by excessive medial
placement of any implant, as tight skin usually pushes the
implant laterally and the thin skin results in distinctly visible
edges. So while the submammary does have the potential to
place implants more medially, this amounts to more of a
liability than an advantage.
Physical evaluation
Until experienced, most surgeons believe that an operation is
all about what happens the day of surgery. In fact, it is the decisions
that lead up to surgery that often have the most long-term
effects on a result. This is particularly true of breast augmentation,
where patient wishes, patient anatomy, and surgeon
judgment converge. This topic is more important than pocket
choice or any other issue with breast augmentation alone. The
following are the most important of these points:
Patient education
The patient must be informed about the limitations of her
tissue, so that her expectations are met. She must anticipate
all trade-offs with respect to issues such as tissue coverage,
animation, correction of ptosis, etc. When patients participate
in these choices and sign off on them, the incidence of revision
surgery is reduced and patient satisfaction increases.
Determination of ideal implant size
A patient is asked to decide whether she wants an implant
that fi ts properly within her tissue, or she wants to force a
certain size into her breasts without regard for creating an
unnatural result in the short term and causing permanent
tissue changes in the long term. Informed patients will usually
select the latter. In that case, using the base width, skin stretch,
and degree of envelope fi ll, the ideal implant size for that
patient ’ s breast is determined. Larger will have an upper convexity
and look more full, stuffed, or fake. Smaller will have
a concave upper pole and look emptier. breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai
Determination of need for coverage and for
muscle release
The dual plane preserves coverage and allowing coverage
where it is needed. These two opposing characteristics need
to be evaluated in all patients.
Coverage
It is always a goal to maintain as much coverage as possible,
sacrifi cing coverage only when there is a reason to do so. With
the exception of patient request (after being fully informed),
a dual-plane approach is suggested to all. If coverage is < 2 cm
of pinch at the upper pole, then a submammary approach
will not even be offered. If pinch < 5 mm at the IMF, serious
consideration is given to not releasing the muscle to create
the dual plane, choosing instead to use a partial retropectoral
pocket. In such situations, the long-term benefi ts of preserving
maximal coverage often outweigh animation deformities,
widening of the intermammary distance, and the predictability
and crispness of the inframammary fold position.
Muscle release
The breast is examined for lower pole constriction or glandular
ptosis that might necessitate controlled release of the
muscle from the gland. While one might decide specifi cally
preoperatively to perform a dual plane type II or type III, the
surgeon should always start by dissection a type I, and then
examine and feel the breast, releasing as much as is necessary
during the operation.
Need for mastopexy
Many patients see plastic surgeons for a breast augmentation
following lactation or weight loss. For some of these women,
mastopexy is the appropriate procedure. Not wanting scars,
some of these patients either receive an implant that fi lls, but
is larger than they wish, or an implant of the size they want
but which creates inadequate fi ll. In either case, and in particular
in the case of the larger implants, the result is aesthetically
compromised, and the already stretched skin stretches
more and deteriorates with time. I have seen many such
patients who had received submammary augmentations, and
have tried this on my own patients. If followed long enough,
the results are frequently unsatisfactory. Neither is the dual
plan an answer for these patients; if the nipple (N) is below
the fold, if N : IMF distance is > 9.5 cm on maximum stretch,
or if substantial parenchyma lays caudal to the inframammary
fold, mastopexy must be considered, and augmentation
should either not be attempted or only performed on the
patient who clearly demonstrates an understanding of the
limitations of such a procedure (see Fig. 54.8 ).
Anatomy
The pectoralis major muscle has origins along the clavicle,
sternum, and the 4th – 6th ribs along the IMF, and inserts onto
the humerus, causing fl exion and internal rotation. Studies
0060_ch54_9780702031687.indd 683 4/8/2009 3:33:48 PM
G
Section 11: The breast
Aesthetic Plastic Surgery
684
have demonstrated that the pectoralis origins along the IMF
can be released without loss of strength or coordination.
What is most relevant to the dual plane is the recognition
that the deep surface of the pectoralis glides over the chest
wall. It is anchored like a trampoline on three sides to the
humerus, clavicle, and ribs. Like a trampoline released on one
edge, the muscle will retract strongly away from the side of
the release.
The only thing that holds it in place – in distinct contrast
to its deep surface – is that its superfi cial surface is tightly
bound to the deep surface of the gland. The superfi cial surface
of the muscle gives rise to the Cooper ’ s ligaments and fi brous
tissue that ramify throughout the breast. These attachments
help hold the caudal edge of the muscle inferiorly, thereby
maintaining coverage to the lower pole of the implant.
Following careful release of the muscle along the inframammary
fold, the surgeon will observe the muscle “ window
shade ” , sliding superiorly 1 – 2 cm. However, if there was an
inadvertent dissection on the superfi cial surface of the muscle,
thereby disrupting some of the fi bers connecting the muscle
to the overlying gland, the muscle will window shade far
more, sacrifi cing what might be intended coverage of the
lower pole.
This point is most emphasized when creating a retropectoral
pocket following a submammary capsulectomy. Even if
the pectoralis origins along the IMF are left intact, the caudal
edge of the muscle window shades very high superiorly; if
those origins are released, it may move so high that it cannot
even cover the implant at all. Understanding this dynamic is
critical to the dual plane approach.
Technical steps
See Table 54.2 ; see also Fig. 54.1 .
Though a dual plane dissection can be done from all
incisions, the inframammary incision allows the greatest
degree of visualization and control of the dual plane pocket.
Most specifi cally, it allows preservation of all the attachments
between the muscle and the overlying gland, so that
if they need to be dissected, it can be done in a specifi c
and controlled manner. Dissection from the periareolar
incision down to the inframammary fold or the proposed
level of transection of the muscle invariably results in some
degree of inadvertent disconnection of the muscle from the
overlying gland, thereby resulting in unintentional superior
elevation of the muscle, creating for example a dual plane
type II or III when a type I was the goal. I frequently
perform revision surgery on patients who had periareolar
augmentation in which the operative note described the
procedure as “ partial retropectoral ” and described only division
of the muscle along the inframammary fold, yet the
caudal edge of the muscle is frequently found well above
the upper border of the areola, beyond what is even considered
a dual plane III. This may be due to a combination
of a bit of release of the muscle along the sternum, but it
seems more commonly due to a release of the attachments
of the superfi cial surface of the muscle from the gland
simply as part of the tunneling process to reach the inframammary
fold. Unless a DP II or III is a goal, a surgeon
should probably perform dual plane pocket surgery from
the inframammary incision until they have gained substantial
experience.
Many surgeons divide the muscle along the inframammary
fold and describe the procedure as “ half over – half under ” ,
or even “ partial retropectoral ” , which is exactly what is
described as a dual plane type I. Whatever the label, these
surgeons should always be cognizant that the loss of tissue
coverage from a periareolar incision is always a risk unless
extremely fastidious dissection is done.
Table 54.2 Technical steps
Description Indication Goal
Partial retropectoral Pectoralis attached to
sternum and to IMF
IMF pinch < 5 mm Maintain maximum coverage
Dual plane type I Same plus complete division
of pectoralis along IMF
All parenchyma above IMF; gland
adherent to muscle; A : IMF on
maximum stretch 4 – 6 cm
Small sacrifi ce in coverage to increase IMF
accuracy; reduce animation deformity;
allow implant to sit at bottom of pocket
Dual plane type II Same plus pectoralis released
from overlying gland and
allowed to slide to about the
lower border of the areola
Most parenchyma above IMF; looser
attachments of gland to muscle with
some sliding of gland over muscle;
stretched lower pole skin with A : IMF
under maximum stretch 5.5 – 6.5 cm
More sacrifi ce in lower pole muscle
coverage in order to reduce risk of mobile breast augmentation dubai
breast enlargement dubai
breast implants dubai
breast surgery dubai
non surgical breast augmentation dubai
breast surgery in uae
boob job dubai
parenchyma from sliding off of muscle,
better fi ll of loose envelope
Dual plane type III Same plus greater release of
pectoralis from gland,
allowing it to slide to about
the upper border of the
areola
Ptosis with one-third or more of
parenchyma below level of anticipated
IMF with patient standing; substantial
sliding of gland over muscle; more
stretched lower pole skin with A : IMF
under max stretch 7 – 8 cm or constricted
lower pole breasts
Most sacrifi ce in lower pole muscle
coverage to allow maximal contact of
implant against gland; allows for maximal
scoring/reshaping of gland to allow
maximal expansion
0060_ch54_9780702031687.indd 684 4/8/2009 3:33:48 PM
G
Chapter 54 The dual plane approach to breast augmentation
685
Likewise, a DP I, involving only the release of the pectoralis
along the inframammary fold, can be undertaken from
the transaxillary incision. Unlike a blunt and blind transaxillary
approach which risks uneven release of the muscle and
imprecise level of the inframammary fold, a true DP I transaxillary
should be done with a bloodless, endoscopic technique.
Creating a DPII or III, however, involves retrograde
dissection from the transaxillary incision. This remains on the
technical fringe at this time, and should be undertaken by
surgeons experienced with endoscopic transaxillary partial
retropectoral pocket creation after experience with the dual
plane for a variety of situations from the inframammary
incision.
IMF approach
See Fig. 54.13 .
The fi rst step is to determine the ideal position of the
inframammary fold. It is calculated from the nipple with the
tissue placed on maximum stretch. In general, the standard
of 7 cm for a base width of 11 cm, 8 cm for a base width of
12 cm, and 9 cm for a base width of 13 cm holds true. If the
inframammary fold is already at that height, it does not need
to be altered.
An incision is made at the proposed inframammary fold.
Dissection is carried straight down to the muscle fascia with
the electrocautery, taking care not to skive inferiorly. There is
a natural tendency of the cut edge of the tissue to pull inferiorly,
so the dissection may angle superiorly, but only for the
purpose of not undercutting the skin edge and inadvertently
lowering the fold more than intended, if at all.
The fascia is scored carefully with the cautery, so that the
muscle is visible. Place in a double-ended or army-navy
retractor with the tip pointed towards the medial border of
the areola. With no horizontal dissection yet made, there will
be little to hold the tissue up onto the blade of the retractor,
so use the ulnar fi ngers of the retractor holding hand to pull
the tissue onto the blade. Lift up towards the ceiling. Only
the pectoralis will tent up. If the muscle does not tent at this
point, it may be that the muscle is tight, or it may be that it
is not the pectoralis. To ensure that it is pectoralis, and neither
serratus, rectus, nor intercostals, touching it with the cautery
will make the pectoralis in the upper chest contract. If still
not clear, only then dissect just a couple of millimeters along
the muscle surface in a cephalad direction. These are the
important fi bers that you want to preserve in order to hold
the muscle down after you release along the inframammary
fold, so sacrifi ce no more than necessary for the anatomy to
be clear. This will allow you to see the fi bers of the muscle,
and allow some tissue to lie over the blade of the retractor,
thereby allowing the pectoralis to tent up.
Again advance the retractor blade to the edge of the muscle,
pointing the blade to the medial border of the areola, pulling
the breast tissue onto the retractor, and lifting toward the
ceiling. Because it is loose on its deep surface, the pectoralis
will tent upwards. Holding your hand down onto the
abdomen so that the cautery is horizontal, sweep gently the
taught pectoralis fi bers that appear vertical in front of you.
Use hand switching monopolar forceps, as it allows precise
control of blood vessels by squeezing, but so too can it be
held together and used as a Bovie pencil.
So long as it tents, it is pectoralis. So long as your cautery
is horizontal and parallel to the chest wall, the chest is safe.
Keep advancing the retractor forward and lifting up after every
stroke of the cautery. With each motion of the cautery and
repositioning of the retractor, the muscle will tent higher and
the plane through the muscle will become more obvious.
With this maneuver, you will very quickly get through the
muscle, and will see the subpectoral space. Free up areolar
tissue that is immediately in front of the incision, and then
turn the retractor blade medially along the inframammary
fold towards the sternum. Controlling the tension of the
retractor blade on the muscles with fi ngers on the outside of
the breast, use the cautery to take down the muscle about
1 cm above the proposed inframammary fold. This may serve
as a shelf to help support the implant; it prevents over lowering
of the fold; and it allows point coagulation of intramuscular
blood vessels. Cut through the muscle and the overlying
fascia. This should be bloodless and very easy to visualize.
In fact, this dissection is so anatomic, that you should
expect to be able to do it without needing to place a single
four by eight into the pocket. Look beyond the tissue plane
immediately in front of you, anticipating and seeing the perforators
ahead of time.
Continue all the way to the sternum, but do not proceed
up the sternum at all. If you are unclear where this point is,
mark it with an “ X ” externally on both sides preoperatively.
Continue the dissection sweeping superolaterally, and
then sweeping inferiorly. This helps to fi nd the plane between
the pectoralis major and pectoralis minor, which are more
intertwined if the dissection in that area starts inferolaterally
instead of superolaterally.
Irrigate with antibiotic solution and inspect the pocket.
Take note of the long, narrow V -shaped trough where the
muscle was released inferomedially and window shaded a
bit superiorly. Inspect where the cut edge of the pectoralis
is relative to your incision; sometimes it is just a few millimeters
beyond it, and sometimes it is already window-shaded
several centimeters. This will vary based upon how cleanly
you got through the pectoralis and how tight the given
patient ’ s connections between the pectoralis and breast tissue
are.
Place a fi nger in the incision and feel the lower border of
the muscle and lift up, taking note of the position of the
muscle through the skin as shown by the position of your
fi nger. This inspection process is not just important in order
to defi ne what you need to do for that specifi c patient, but
done repeatedly, it provides the surgeon with a valuable experience
about the dynamics of the muscle and the soft tissue.
If the intention is to do a dual plane I, by virtue of the
muscle release, the dual plane portion of the dissection is
complete. The implant can be placed and the incision
closed.
If the goal is to do a dual plane type II or type III, then
now is the time to do a release. This release is gradual and
incremental. It cannot be overstated that substantial differences
in position of the caudal edge of the pectoralis are
created by just several millimeters of dissection. Surgeons ask
0060_ch54_9780702031687.indd 685 4/8/2009 3:33:48 PM
G
Section 11: The breast
Aesthetic Plastic Surgery
Fig. 54.13 A & B , After the retropectoral pocket is made, the pectoralis is divided 1 cm above the proposed inframammary fold. Note the use of the ulnar digits
on the retractor hand pressing the muscle under tension so that it splits as it is divided. The superior and inferior cut edges are visible. When this is divided up
to the sternum, a dual plane I will have been created, as shown in this photo. Depending upon the tension of the tissues, the muscle will window shade up a
centimeter or two; in this case the muscle is about half the width of the retractor blade above the IMF. C , To go from a dual plane I to a II or III, the fi brous
connections between muscle and the overlying parenchyma must be taken down. Just a few sideways swipes with the cautery is enough to cause signifi cant
movement of the muscle. D , After just a few swipes of the cautery freeing up some attachments of the muscle to the gland, the muscle moves cephalad. The
fresh yellow fat shows the signifi cant motion of the muscle relative to the last photo. Again, note the use of the ulnar digits against the retractor to create
tension at the muscle parenchyma border, thereby making the dissection more precise and facile. E , When converting to a DP I to a II or a III, note how the
hand and the retractor are used as a unit to create tension at the muscle/parenchyma interface. F , Here the release is being done more laterally. It can be
adjusted on each breast exactly as the conditions necessitate. G , Copious irrigations with “ Adams ” solution (50 mL Betadine, 80 mg gentamicin, 1 g Ancef in
500 mL NS) is used throughout the operation. Note the yellow fat visible just beyond retractor; cut edge of muscle is just visible. H , In this case, the muscle is
released to the lower border of the areola, which is a so-called dual plane II. When it is released to about the upper border of the areola, it is termed a DP III.
A
G H
E F
C D
B
0060_ch54_9780702031687.indd 686 4/8/2009 3:33:49 PM
G
Chapter 54 The dual plane approach to breast augmentation
687
why they can ’ t dissect between the muscle and the gland
before the muscle dissection, and the reason is that such small
amounts of dissection result in such signifi cant movement of
the muscle, that it is impossible to predict where the muscle
will end up before dissecting the pocket and releasing the
IMF.
With the curved end of a double-ended retractor placed in
the incision, abutting to the caudal edge of the muscle, but
with only breast tissue within it, use the other fi ngers in the
retractor hand to push in on the breast, so that together with
the retractor, it is putting tension between the muscle and the
overlying gland.
Visualize the fascial connections between the muscle and
gland, and use the cautery to gradually cut these, using sideways
sweeping motions. You will see the muscle quickly pull
away from the retractor and slide upwards. Once it does this
even for several millimeters, move the retractor medially and
laterally and repeat this process where you feel there is restriction
by the muscle.
Rather than repeating this motion in the same area, keep
moving around, as this will give the most control over the
fi nal position of the muscle.
While illustrations suggest dual plane type I, II, and III as
distinct entities, they are part of a continuum of options.
Their designations are designed as a guide to enable us to
think about a clinical situation and compare notes. But in any
given patient, the muscle does not necessarily end exactly at
the lower border of the areola (type II) or the upper border
of the areola (type III). Rather, the release is made to the
extent that is necessary to achieve the exposure of the implant
to the gland of the breast.
The most important point is not to overdo it. You can
always release more, but once it is released, it is diffi cult if
not impossible to pull the muscle back down. Put your fi nger
back in as you did before, and note the chance in position of
the muscle relative to before you did the release. Feel all along
its edge, and go back and release more where you feel it is
necessary.
If you feel bands within the breast that are restricting
expansion, such as with a constricted lower pole, or when the
IMF had to be lowered with a tight IMF, now would be the
time to score the lower pole, much as you might have done
with a submammary pocket.
Irrigate again with antibiotic solution, recheck for
bleeding, and place the chosen implant close per the usual
routine.
Postoperative care
With precise visualization of the pocket, no special bras or
straps are necessary to try to push the implant into a pocket.
Tape or a Steri-strip over the incision is the only dressing that
is used.
With bloodless dissection, no special bandages are necessary
to create compression, and early motion is not just
allowed, it is ordered. Patients move their arms over their
head in the recovery room in a gradual jumping jack type of
motion. They go home, take a nap, and then are instructed
to continue their exercises every hour while awake, take a
shower, and leave the house for dinner. They may drive a car
when they feel that they can safely make unrestricted movements,
which is usually in two to four days. They are encouraged
to do all normal daily activities that do not involve
particular exertion, such as opening and closing car doors,
putting on a seatbelt, lifting a baby, emptying a dishwasher,
or making dinner. They may return to the gym after three
weeks, though some surgeons allow this after two weeks.
With gentle, precise, and bloodless dissection, patients are
only given narcotics through their time in the recovery room,
and are managed over 95% of the time with ibuprofen alone
at home.
Complications
There is no complication of dual plane that has not been
well-described with either the submammary or partial retropectoral
operations. The issue with dual plane is not that
there are new complications, but that the patient and surgeon
understand its limitations. So long as these trade-offs are well
understood preoperatively, they are accepted later.
For instance, in cases of extreme mobility of the breast over
the underlying chest wall, inferior sliding of tissue may still
occur with the dual plane approach. It is my impression that
in extreme cases of laxity this may occur more with the dual
plane than the submammary approach, but this is diffi cult to
quantify because even the submammary approach does not
always totally solve the problem.
Though dual plane can reduce muscle animation relative
to partial retropectoral, it cannot eliminate it to the same
extent as the submammary pocket. Patients need to be aware
of this, and make their decision about the pocket they
prefer.
0060_ch54_9780702031687.indd 687 4/8/2009 3:33:53 PM
G
Pearls & pitfalls
Pearls
• When you have a choice in breast augmentation, always
prioritize coverage. This will make the breast more natural in
the short term and reduce the likelihood of diffi cult to
correct long-term problems.
• Point out all limitations a patient ’ s pre-existing anatomy
poses on her result preoperatively. This will help her to let
you do what you think is best for her, and will prepare her to
accept trade-offs and shortcomings in her result later.
• With the dual plane, dissect a partial retropectoral pocket
fi rst. The more directly you are able to get behind the
muscle, the less it will move superiorly after muscle division.
• Do not force yourself to choose which type of dual plane you
will do; these are not so much distinct entities as points on a
path. You should feel the breast during the dissection and
adjust the dissection accordingly.
• Demand of yourself to make a gentle and bloodless pocket
dissection so that your patients have an easy recovery.
Pitfalls
• The dual plane is not perfect, and though it maximizes most
of the advantages and minimizes most of the disadvantages
of either the submammary or partial retropectoral pockets,
neither the surgeon nor the patient should think that it is
perfect.
• It is easy to over-dissect the attachments between the
muscle and gland; avoid excessive dissection in that plane
before dividing the pectoralis along the IMF, and then only
release gradually and incrementally.
• Do not release the pectoralis ever along the sternum; it
creates deformities that are diffi cult to correct.
Summary of steps
1. Partial retropectoral: Pectoralis origins left intact along
sternum and IMF.
2. Dual plane type I: Pectoralis origins left intact along
sternum, but divided along the IMF.
3. Dual plane type II: Same plus pectoralis released from
overlying gland and allowed to slide to about the lower
border of the areola.
4. Dual plane type III: Same plus greater release of pectoralis
from gland, allowing it to slide to about the upper border
of the areola.
Further reading
Adams WP Jr . The process of breast augmentation: Four sequential
steps for optimizing outcomes for patients . Plast Reconstr Surg
2008 ; 122 ( 6 ): 1892 – 1900 .
Adams WP Jr , Rios JL , Smith SJ . Enhancing patient outcomes in
aesthetic and reconstructive breast surgery using triple
antibiotic breast irrigation: Six-year prospective clinical study .
Plast Reconstr Surg 2006 ; 118 ( 7S ): 46S – 52S .
Spear SL , Carter ME , Ganz JC . The correction of capsular
contracture by conversion to “ dual-plane ” positioning:
Technique and outcomes . Plast Reconstr Surg
2006 ; 118 ( 7S ): 103S – 113S .
Tebbetts JB , Adams WP . Five critical decisions in breast
augmentation using fi ve measurements in 5 minutes: The
high fi ve decision support process . Plast Reconstr Surg
2006 ; 118 ( 7S ): 35S – 45S .
Tebbetts JB . Achieving a zero percent reoperation rate at 3 years in
a 50-consecutive-case augmentation mammaplasty premarket
approval study . Plast Reconstr Surg 2006 ; 118 ( 6 ): 1453 – 1457 .
Teitelbaum S . The Inframammary approach to breast
augmentation . Clin Plast Surg 2009 ; 36 ( 1 ): 33 – 43
Section 11: The breast
Aesthetic Plastic Surgery
688
0060_ch54_9780702031687.indd 688 4/8/2009 3:33:53 PM